Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017315	u-amyl	u/l (u/l)	2093	2586	0.04%
3017315	u-amyl	— (—)	166	178	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Acute pancreatitis

303

279

11.22

284.60

1.6

1.1

948.20

235.98

u/l

3.42

259

263

Abdominal and pelvic pain

748

692

5.48

284.42

1.3

1.1

315.71

375.32

u/l

0.35

690

648

Acute pancreatitis (for exclusion)

303

315

9.93

261.25

1.6

1.2

948.20

260.38

u/l

3.20

259

293

Disorders of gallbladder, biliary tract and pancreas

794

1220

4.24

256.26

1.4

1.1

487.75

214.97

u/l

3.59

716

1162

Symptoms and signs involving the digestive system and abdomen

708

692

5.17

254.32

1.3

1.1

333.42

375.32

u/l

0.22

652

648

Chronic pancreatitis

182

165

11.41

172.91

1.9

1.1

534.82

267.52

u/l

1.20

155

157

GASTRO-related operations

488

528

4.67

158.58

1.3

1.1

346.35

249.92

u/l

0.98

450

499

Any gastric operation

488

528

4.67

158.58

1.3

1.1

346.35

249.92

u/l

0.98

450

499

Cholelithiasis, broad definition with cholecystitis

537

1124

3.30

126.20

1.3

1.1

234.85

212.72

u/l

0.37

494

1070

Other diseases of intestines

649

1273

2.98

123.01

1.4

1.2

276.60

359.74

u/l

0.74

611

1185

Cholelithiasis

509

1114

3.23

116.55

1.3

1.1

233.01

212.71

u/l

0.32

467

1060

Low back pain

459

1056

3.37

115.83

1.4

1.2

230.21

384.76

u/l

2.12

439

986

Pain (limb, back, neck, head abdominally)

383

470

4.10

107.93

1.3

1.1

341.97

396.03

u/l

0.24

354

432

Alcohol-induced chronic pancreatitis

108

11.97

105.55

1.8

1.2

596.71

465.61

u/l

0.22

Diseases of oesophagus, stomach and duodenum

634

1432

2.71

102.81

1.4

1.2

269.32

324.35

u/l

0.68

581

1351

Substance abuse, excluding more controls

367

928

3.49

101.30

1.4

1.2

292.55

345.07

u/l

0.42

337

861

384

1072

3.32

99.23

1.4

1.2

425.18

312.34

u/l

0.81

346

1005

396

1105

3.24

97.72

1.4

1.2

457.22

304.05

u/l

1.23

358

1036

Alcohol use disorder, Swedish definition

369

1037

3.33

96.32

1.4

1.2

462.84

314.68

u/l

1.07

333

973

Lower back pain or/and sciatica

598

1593

2.62

94.76

1.4

1.2

241.02

338.09

u/l

1.53

572

1478

Dorsalgia

560

1091

2.79

93.00

1.4

1.2

266.39

380.69

u/l

1.30

533

1017

Other dorsopathies, not elsewhere classified

565

1097

2.73

89.30

1.4

1.2

263.16

385.60

u/l

1.44

529

1022

Gastrointestinal diseases

298

356

4.21

86.83

1.3

1.1

344.10

218.75

u/l

1.74

274

338

Mental and behavioural disorders due to psychoactive substance use

375

1157

3.08

86.56

1.4

1.2

297.37

340.41

u/l

0.38

344

1079

Substance abuse

367

1140

3.10

85.86

1.4

1.2

292.55

340.60

u/l

0.43

337

1062

Cholecystectomy

427

1333

2.85

84.63

1.4

1.2

304.33

316.02

u/l

0.07

393

1241

Tramadol

453

1023

2.86

83.04

1.4

1.2

280.60

370.72

u/l

0.77

426

952

Sciatica+with lumbago

300

838

3.42

82.47

1.3

1.2

233.46

410.50

u/l

1.68

286

777

Nausea and vomiting

145

238

6.04

82.20

1.4

1.2

314.42

258.71

u/l

0.27

134

217

Hernia of abdominal wall, postoperative

111

142

7.91

81.11

1.6

1.2

221.60

293.48

u/l

0.63

103

129

General symptoms and signs

595

1195

2.51

78.67

1.4

1.2

274.72

360.58

u/l

0.95

555

1117

Headache

375

1065

2.96

78.54

1.4

1.2

263.02

367.64

u/l

1.04

353

994

Irritable bowel syndrome

187

413

4.58

77.92

1.5

1.2

237.59

320.17

u/l

0.96

177

376

Diverticular disease of intestine

392

885

2.96

76.94

1.4

1.2

278.52

393.48

u/l

0.64

368

818

Pain in throat and chest

471

1076

2.69

75.97

1.4

1.2

239.08

368.76

u/l

1.93

436

1012

Other functional intestinal disorders

255

701

3.49

72.34

1.5

1.2

195.25

351.03

u/l

1.93

234

642

Pain in joint

252

446

3.76

71.28

1.4

1.1

248.84

396.22

u/l

0.92

240

411

Mental and behavioural disorders due to alcohol

312

1009

3.03

70.71

1.4

1.2

325.73

353.31

u/l

0.18

284

942

Parasetamol

406

718

2.90

70.66

1.3

1.2

350.26

345.60

u/l

0.02

378

665

Oxycodone

217

560

3.78

69.55

1.5

1.2

195.15

437.54

u/l

2.26

211

515

Other soft tissue disorders, not elsewhere classified

485

1202

2.50

68.38

1.3

1.2

244.40

306.57

u/l

0.83

452

1126

Abnormalities of breathing

470

1120

2.50

65.60

1.2

283.96

363.84

u/l

0.49

433

1055

Other intervertebral disc disorders

426

1000

2.62

65.57

1.2

285.37

392.80

u/l

0.93

395

933

Mental and behavioural disorders due to alcohol, excluding acute intoxication

279

911

3.08

65.54

1.5

1.2

319.81

371.68

u/l

0.36

254

849

Alcohol use disorder, ICD-based

263

839

3.16

64.45

1.5

1.2

330.47

383.85

u/l

0.34

239

780

Dorsopathies

517

1102

2.40

63.34

1.3

1.2

249.64

384.76

u/l

1.76

479

1027

Spondylopathies

395

907

2.66

62.37

1.3

1.2

194.30

407.00

u/l

3.21

369

845

Codeine

481

1103

2.41

60.45

1.4

1.2

306.90

357.57

u/l

0.38

450

1027

Gastro-oesophageal reflux disease

356

1238

2.56

57.65

1.2

281.24

330.29

u/l

0.24

323

1164

Pain in limb

395

1161

2.47

56.71

1.2

199.33

306.96

u/l

2.25

369

1089

Opioids

491

1115

2.32

56.37

1.4

1.2

275.73

356.13

u/l

0.78

460

1038

Alcohol dependence

185

522

3.58

55.28

1.6

1.2

319.06

476.87

u/l

0.86

165

484

Other diseases of biliary tract

101

7.78

55.26

1.3

1.2

252.93

226.33

u/l

0.10

Other headache syndromes

244

839

2.93

52.55

1.4

1.2

235.71

324.14

u/l

0.83

226

775

Pain, not elsewhere classified

161

428

3.79

52.51

1.5

1.2

198.56

342.90

u/l

1.68

150

393

Functional dyspepsia

164

444

3.73

52.13

1.4

1.2

186.18

299.85

u/l

2.33

153

410

Fever of other and unknown origin

271

920

2.75

50.99

1.3

1.2

275.29

359.46

u/l

0.64

260

853

Psychiatric diseases

535

1250

2.15

50.87

1.4

1.2

269.21

340.41

u/l

0.77

496

1165

Shoulder lesions

395

1015

2.39

50.77

1.3

1.2

282.67

315.36

u/l

0.25

374

947

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

161

442

3.67

50.11

1.3

288.66

337.99

u/l

0.24

149

408

Concussion

255

785

2.83

49.87

1.3

1.2

313.58

329.44

u/l

0.08

242

744

Anxiety disorders, excluding more controls

406

1165

2.32

49.80

1.3

1.2

256.75

343.27

u/l

0.90

379

1086

Any mental disorder

540

1278

2.12

49.75

1.4

1.2

269.18

336.47

u/l

0.73

501

1191

Intracranial trauma

289

808

2.69

49.50

1.3

1.2

305.02

328.60

u/l

0.14

275

765

Anaemias

138

207

4.47

48.69

1.4

1.2

246.61

361.80

u/l

0.41

125

198

Pain in thoracic spine

102

205

5.03

47.80

1.3

1.2

181.70

457.14

u/l

1.71

190

Lumbar disc prolapse

300

938

2.55

47.29

1.3

1.2

293.70

402.01

u/l

0.80

279

873

Paralytic ileus and intestinal obstruction

141

368

3.86

47.24

1.3

1.2

296.61

418.90

u/l

0.58

134

335

Infections, IBD-co-morbidities

128

5.68

46.95

1.2

176.83

471.22

u/l

1.12

122

Mood disorders, excluding more controls

448

1252

2.19

46.81

1.3

1.2

278.16

340.53

u/l

0.58

416

1165

Codeine or tramadol medication

558

1536

2.02

46.49

1.3

1.2

304.87

321.92

u/l

0.14

525

1436

Other antidepressants

508

1265

2.10

46.28

1.3

1.2

292.99

339.49

u/l

0.41

469

1188

Dyspnoea

435

1555

2.15

46.18

1.2

188.84

346.91

u/l

4.25

400

1455

Asthma, excluding more controls

373

847

2.36

44.64

1.4

1.2

234.25

384.12

u/l

1.72

349

794

Constipation

427

1429

2.15

44.55

1.2

276.50

326.56

u/l

0.26

387

1340

Symptoms and signs involving the circulatory and respiratory systems

475

1125

2.12

43.91

1.3

1.2

269.31

363.52

u/l

1.13

431

1060

Alcohol abuse, main dg, excluding more controls

109

250

4.41

43.57

1.6

1.2

275.98

441.02

u/l

0.96

232

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

153

190

4.05

42.96

1.3

1.1

352.26

405.11

u/l

0.16

140

178

Other disorders of fluid, electrolyte and acid-base balance

174

532

3.18

42.92

1.3

1.2

291.34

390.40

u/l

0.45

159

499

Diarrhoea and gastroenteritis of presumed infectious origin

350

1421

2.25

42.91

1.3

1.2

242.72

333.36

u/l

1.23

320

1330

Substance use, excluding alcohol

130

344

3.82

42.82

1.5

1.2

215.28

410.77

u/l

1.66

120

321

Asthma (only as main-diagnosis), excluding more controls

336

847

2.37

42.20

1.3

1.2

222.27

384.12

u/l

1.95

318

794

Asthma (mode)

377

923

2.25

41.19

1.3

1.2

235.59

367.24

u/l

1.58

356

866

Spondylosis

245

809

2.61

41.18

1.3

1.2

179.37

410.21

u/l

3.15

228

753

Benzodiazepine use

475

1695

2.00

41.12

1.3

1.2

254.10

328.84

u/l

0.98

443

1586

Intestinal infectious diseases

445

1714

2.03

40.72

1.2

254.90

328.63

u/l

1.00

411

1605

Asthma

379

912

2.24

40.54

1.4

1.2

236.17

369.35

u/l

1.58

355

855

Dysphagia

102

237

4.33

40.05

1.2

1.1

152.43

423.64

u/l

1.29

216

Diseases of the digestive system

241

949

2.55

39.85

1.4

1.2

246.55

356.15

u/l

1.13

221

880

Oral corticosteroids

501

1556

1.95

39.15

1.4

1.2

311.01

321.49

u/l

0.05

475

1452

Inflammatory bowel disease treatment related agents

535

1591

1.92

38.89

1.4

1.2

290.31

319.47

u/l

0.18

504

1484

Malaise and fatigue

229

732

2.62

38.58

1.2

201.18

375.77

u/l

1.62

215

676

Rotator cuff syndrome

297

946

2.34

38.45

1.3

1.2

287.56

321.89

u/l

0.24

280

888

Asthma (only as main-diagnosis)

340

912

2.26

38.42

1.3

1.2

221.73

369.35

u/l

1.86

321

855

Intestinal adhesions without obstruction

6.77

38.21

1.3

1.1

349.85

351.56

u/l

0.00

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

115

307

3.79

37.48

1.4

1.3

239.40

316.70

u/l

0.54

105

286

Soft tissue disorders

464

1213

1.99

36.87

1.4

1.2

303.30

311.22

u/l

0.04

428

1137

Other/unspecified dorsalgia

174

608

2.86

36.19

1.3

1.2

254.99

433.17

u/l

1.17

169

558

Mood [affective] disorders

478

1644

1.92

36.16

1.3

1.2

273.77

329.49

u/l

0.63

446

1538

Myalgia

125

362

3.48

36.07

1.3

1.2

237.55

326.12

u/l

0.84

117

332

Mood disorders

478

1645

1.91

35.94

1.3

1.2

273.77

329.39

u/l

0.63

446

1539

Poisoning by medicine

136

418

3.28

35.74

1.4

1.3

291.97

360.64

u/l

0.33

126

386

404

1249

2.03

35.61

1.2

288.16

343.48

u/l

0.45

373

1172

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

404

1249

2.03

35.61

1.2

288.16

343.48

u/l

0.45

373

1172

Anxiety disorders

423

1521

1.98

35.52

1.3

1.2

256.33

336.11

u/l

1.03

396

1425

514

1439

1.89

35.40

1.3

1.2

272.85

342.90

u/l

0.75

480

1342

Alcohol abuse, main dg

109

292

3.78

35.39

1.6

1.2

275.98

465.99

u/l

1.24

267

Neurotic, stress-related and somatoform disorders

418

1507

1.98

35.17

1.3

1.2

258.06

337.43

u/l

1.01

391

1412

Anxiety (asthma-related co-morbidities)

277

953

2.30

35.00

1.4

1.2

266.58

325.25

u/l

0.49

254

892

Neurological diseases, wide definition

150

216

3.50

34.97

1.3

1.2

401.69

404.40

u/l

0.01

137

207

Depression or dysthymia

324

817

2.23

34.83

1.5

1.2

305.82

369.54

u/l

0.40

304

762

Episodal and paroxysmal disorders

502

1358

1.90

34.75

1.3

1.2

322.32

321.57

u/l

0.00

465

1273

Cervical disc disorders

171

613

2.81

34.32

1.2

192.03

423.51

u/l

2.47

162

565

Depression

443

1590

1.92

34.21

1.3

1.2

261.45

327.25

u/l

0.81

412

1489

Injuries to the head

492

1728

1.86

33.88

1.3

1.2

289.37

320.75

u/l

0.29

469

1606

First line medication for Crohn's disease

508

1491

1.86

33.77

1.4

1.2

318.94

315.55

u/l

0.02

477

1390

Other or unspecified ileus, impaction or obstruction

243

3.98

33.71

1.3

1.1

233.90

385.85

u/l

1.22

219

ILD medications

516

1541

1.84

33.21

1.4

1.2

291.35

321.09

u/l

0.18

486

1436

Symptoms and signs involving cognition, perception, emotional state and behaviour

437

1608

1.91

33.19

1.3

1.2

229.20

334.11

u/l

1.74

403

1509

ILD medications: prednisolone, methylprednisolone, prednisone

498

1521

1.86

32.95

1.4

1.2

304.48

323.19

u/l

0.10

468

1417

Acute alcohol intoxication, ICD10

124

379

3.30

32.94

1.6

1.2

301.87

415.61

u/l

0.76

110

354

Suicide or other Intentional self-harm

147

497

2.98

32.90

1.4

1.3

293.14

351.62

u/l

0.28

136

455

Implicit Sepsis

335

1261

2.07

32.67

1.2

261.13

329.53

u/l

0.66

309

1173

Acute upper respiratory infections

465

1560

1.87

32.46

1.3

1.2

275.98

329.34

u/l

0.51

437

1451

Influenza and pneumonia

473

1688

1.85

32.02

1.2

279.01

326.24

u/l

0.48

435

1585

COPD/asthma related infections

471

1252

1.89

31.94

1.2

282.49

343.13

u/l

0.54

433

1175

COPD/asthma/ILD related infections

471

1252

1.89

31.94

1.2

282.49

343.13

u/l

0.54

433

1175

Asthma, hospital admission 2, infections

271

1229

2.18

31.44

1.3

1.2

202.97

347.75

u/l

2.73

253

1136

Asthma-related infections

271

1229

2.18

31.44

1.3

1.2

202.97

347.75

u/l

2.73

253

1136

Poisoning by drugs, medicaments and biological substances

141

478

2.97

31.43

1.4

1.3

310.03

355.49

u/l

0.21

131

441

Cough

190

718

2.55

31.43

1.2

1.3

223.68

398.64

u/l

1.59

173

674

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

161

587

2.76

31.37

1.3

288.66

330.91

u/l

0.22

149

540

Migraine

227

820

2.37

31.10

1.3

1.2

280.61

302.46

u/l

0.15

220

765

Dizziness and giddiness

336

1358

2.02

30.69

1.3

1.2

233.49

342.28

u/l

1.35

305

1267

Spinal stenosis

212

689

2.42

30.08

1.4

1.2

179.02

435.13

u/l

2.82

196

640

Metabolic disorders

423

1404

1.88

29.75

1.3

1.2

268.82

339.94

u/l

0.82

382

1320

Acute alcohol intoxication

140

491

2.87

29.38

1.5

1.2

292.31

488.21

u/l

1.21

126

456

Other bacterial diseases

418

1562

1.86

29.06

1.2

1.3

244.12

338.26

u/l

1.32

380

1463

Intestinal stricture

155

577

2.71

29.05

1.3

1.2

298.41

353.14

u/l

0.29

148

528

Examination and observation for other reasons

302

878

2.10

28.84

1.3

1.2

200.88

389.87

u/l

2.93

277

831

211

903

2.33

28.84

1.3

1.2

205.38

317.74

u/l

2.13

197

827

Nerve, nerve root and plexus disorders

467

1635

1.80

28.84

1.2

254.41

314.53

u/l

0.85

432

1533

Hypo-osmolality and hyponatraemia

281

3.51

28.68

1.3

1.2

205.00

323.73

u/l

1.13

266

Non-selective monoamine reuptake inhibitors

190

763

2.43

28.39

1.4

1.2

218.01

385.39

u/l

1.68

169

712

Hernia

415

1528

1.85

28.37

1.3

1.2

412.52

303.97

u/l

0.49

376

1429

Certain infectious and parasitic diseases

441

1198

1.85

28.10

1.2

382.24

301.98

u/l

0.39

399

1126

Other gastritis (incl. Duodenitis)

113

360

3.16

28.09

1.5

1.2

381.81

399.14

u/l

0.05

106

335

Cervicocranial syndrome

137

4.72

27.99

1.2

215.66

363.46

u/l

1.03

126

Depression medications

143

234

3.09

27.87

1.3

1.2

423.98

349.80

u/l

0.21

130

225

Neurological diseases

375

973

1.95

27.84

1.2

290.08

332.42

u/l

0.36

338

924

All anxiety disorders

278

1082

2.08

27.52

1.4

1.2

265.92

329.28

u/l

0.59

255

1012

Symptoms and signs concerning food and fluid intake

113

5.09

27.22

1.4

1.2

238.06

299.48

u/l

0.32

107

Other diseases of the digestive system

152

584

2.62

26.79

1.3

1.2

245.00

417.59

u/l

1.27

140

546

Renal tubulo-interstitial diseases

375

1554

1.86

26.69

1.2

215.02

334.87

u/l

2.12

349

1447

Bronchitis

458

1710

1.76

26.63

1.3

1.2

250.44

329.73

u/l

1.02

422

1603

Complications of surgical and medical care, not elsewhere classified

423

1697

1.79

26.58

1.3

1.2

295.58

315.50

u/l

0.12

396

1583

Cystitis

365

1181

1.90

26.40

1.4

1.2

211.24

334.41

u/l

2.03

351

1101

GI-bleeding

152

590

2.59

26.25

1.3

1.2

249.61

415.21

u/l

1.19

140

552

Asthma, unspecified (mode), excluding more controls

217

761

2.25

26.11

1.4

1.2

217.47

393.75

u/l

1.87

198

711

Cervicalgia

287

3.33

25.79

1.4

1.2

260.17

415.38

u/l

0.95

264

Falls/tendency to fall

490

1413

1.74

25.76

1.4

1.2

277.00

335.17

u/l

0.61

456

1319

Gastroduodenal ulcer

121

422

2.88

25.58

1.3

1.2

271.43

414.50

u/l

0.64

109

394

Cardiac arrhythmias

272

874

2.06

25.47

1.2

244.41

413.77

u/l

1.80

247

831

Acute upper respiratory infections of multiple and unspecified sites

322

1259

1.92

25.42

1.3

1.2

284.26

338.60

u/l

0.40

301

1168

Other nutritional deficiencies

286

1426

1.97

25.36

1.4

1.2

294.06

323.59

u/l

0.22

268

1328

Complications of procedures, not elsewhere classified

350

1640

1.85

25.24

1.2

296.03

315.65

u/l

0.10

329

1527

Intracranial injury

246

1153

2.07

25.06

1.3

1.2

282.19

337.11

u/l

0.39

236

1055

Personality disorders, excluding more controls

118

412

2.88

25.03

1.3

1.2

272.99

357.58

u/l

0.42

107

378

Asthma, including avohilmo

499

1710

1.70

25.00

1.3

1.2

223.82

340.57

u/l

2.61

471

1594

Recurrent or chronic depression

180

542

2.41

24.88

1.4

1.2

346.76

359.13

u/l

0.04

170

505

Acute sinusitis

233

1033

2.11

24.87

1.2

1.3

270.06

342.30

u/l

0.58

217

959

Hypertensive diseases (excluding secondary)

234

626

2.18

24.39

1.4

1.2

221.85

460.71

u/l

2.17

213

597

Selective serotonin reuptake inhibitors

426

1270

1.77

24.05

1.2

344.71

339.31

u/l

0.03

395

1192

Other reaction to severe stress, and adjustment disorders

168

715

2.36

23.85

1.4

1.3

240.82

307.14

u/l

0.65

157

663

Migraine with aura

113

396

2.87

23.83

1.3

369.16

264.91

u/l

0.52

107

370

Diseases of liver

164

692

2.38

23.76

1.4

1.2

512.04

351.17

u/l

0.36

150

643

Osteopathies and chondropathies

245

1150

2.03

23.61

1.3

207.98

353.22

u/l

2.43

234

1055

Pneumonias (Asthma/COPD co-morbidities)

423

1697

1.73

23.53

1.2

286.77

323.90

u/l

0.33

389

1589

Chronic lower respiratory diseases

510

1658

1.67

23.48

1.3

1.2

232.45

343.88

u/l

2.33

477

1549

Other specific joint derangements/joint disorders

312

1105

1.90

23.27

1.4

1.2

227.95

362.59

u/l

1.84

294

1031

All pneumoniae

425

1707

1.72

23.22

1.2

286.78

322.81

u/l

0.32

390

1600

Asthma, unspecified (mode)

219

819

2.13

23.15

1.4

1.2

216.53

375.46

u/l

1.76

200

765

Assault

223

3.53

23.15

1.5

1.3

294.47

384.66

u/l

0.53

203

Other disorders of lacrimal gland

159

670

2.39

23.12

1.2

204.85

295.41

u/l

1.71

149

613

Type 2 diabetes, wide definition

313

1079

1.90

23.11

1.2

1.1

155.96

244.98

u/l

4.98

296

1018

Asthma (diagnoses ohter than nonallergic)

366

1769

1.77

23.05

1.4

1.2

220.05

331.82

u/l

2.52

341

1653

Deforming dorsopathies

116

421

2.77

22.94

1.2

230.88

441.91

u/l

1.43

108

386

Condition for Implicit Sepsis (Organ dysfunction codes)

357

1445

1.80

22.90

1.2

1.3

270.72

343.14

u/l

0.74

331

1353

Convulsions, not elsewhere classified

104

352

2.93

22.79

1.4

1.2

261.56

435.29

u/l

0.73

324

Diseases of the musculoskeletal system and connective tissue

225

517

2.19

22.79

1.3

1.2

306.33

396.07

u/l

0.48

209

487

Obesity and other hyperalimentation

269

1385

1.93

22.65

1.4

1.2

279.20

326.98

u/l

0.38

254

1286

Other diseases of urinary system

427

1393

1.73

22.64

1.4

1.2

278.73

329.92

u/l

0.33

400

1294

Cardiovascular diseases (excluding rheumatic etc)

273

794

1.99

22.56

1.3

1.2

260.46

414.63

u/l

1.43

249

758

Obesity

268

1381

1.93

22.56

1.4

1.2

278.86

327.40

u/l

0.39

253

1282

Asthma, hospital admissions , main diagnosis only

349

1760

1.78

22.44

1.3

1.2

221.03

331.46

u/l

2.23

330

1640

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

411

1688

1.72

22.22

1.2

290.76

324.03

u/l

0.28

379

1579

Injuries to the thorax

200

945

2.13

22.07

1.2

1.3

215.14

370.68

u/l

2.14

187

873

Acute gastritis

4.95

21.80

1.3

1.2

360.43

262.38

u/l

0.18

Noninfective enteritis and colitis

212

1028

2.07

21.78

1.2

1.3

296.14

362.95

u/l

0.43

195

946

Hypertension, essential

328

1020

1.84

21.47

1.4

1.2

210.76

395.23

u/l

2.87

296

964

Alcoholic liver disease

160

3.92

21.40

1.5

1.2

324.79

429.68

u/l

0.33

149

Pneumonia, organism unspecified

373

1554

1.74

21.39

1.2

1.3

287.73

334.26

u/l

0.39

345

1453

Soft tissue disorders related to use, overuse and pressure

120

460

2.62

21.37

1.5

1.2

434.96

411.86

u/l

0.04

107

423

Cardiovascular diseases

248

671

2.02

21.01

1.3

1.2

274.33

398.43

u/l

1.04

228

642

Gastric ulcer

248

3.25

20.92

1.4

1.1

303.69

275.84

u/l

0.10

231

Type 2 diabetes

412

1443

1.70

20.86

1.3

1.2

197.28

359.71

u/l

3.79

373

1353

Polyarthropathies

285

1012

1.88

20.76

1.3

1.2

226.58

361.58

u/l

1.72

265

938

Bleeding

339

1401

1.77

20.45

1.3

1.2

223.07

338.07

u/l

2.06

316

1296

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

399

1703

1.68

20.29

1.3

1.2

286.98

321.82

u/l

0.33

367

1594

Diabetes, varying definitions

426

1528

1.67

20.26

1.3

1.2

199.78

353.33

u/l

3.75

389

1432

Other septicaemia

159

696

2.25

20.24

1.3

1.2

188.83

404.81

u/l

2.49

143

647

Implicit bacterial Sepsis

167

694

2.22

20.20

1.2

225.10

417.87

u/l

1.71

151

643

Diabetes mellitus

427

1532

1.67

20.19

1.3

1.2

199.55

353.94

u/l

3.81

390

1436

Schizophrenia or delusion, excluding more controls

127

510

2.48

20.19

1.3

1.2

257.21

381.85

u/l

0.67

119

469

Other disorders of urethra and urinary system

277

1115

1.87

20.18

1.3

1.2

281.82

317.49

u/l

0.14

260

1039

Diabetes, insulin treatment (Kela reimbursement)

419

1536

1.67

20.16

1.3

1.2

187.47

354.01

u/l

4.44

387

1435

Ovarian cyst

168

423

2.31

20.04

1.2

1.3

297.95

303.61

u/l

0.02

159

396

Implicit viral Sepsis

313

2.93

19.96

1.3

1.2

164.67

337.33

u/l

2.72

287

Viral Sepsis

314

2.92

19.85

1.3

1.2

164.67

337.21

u/l

2.73

288

Explicit Sepsis

179

808

2.13

19.85

1.3

1.2

193.79

382.56

u/l

2.46

161

749

Asthma-related pneumonia

156

697

2.25

19.80

1.4

1.2

174.97

402.01

u/l

2.71

148

638

Asthma, hospital admissions 3, pneumonia

156

698

2.24

19.73

1.4

1.2

174.97

401.82

u/l

2.72

148

639

Asthma-related pneumonia or sepsis

156

698

2.24

19.73

1.4

1.2

174.97

401.82

u/l

2.72

148

639

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

243

3.20

19.62

1.5

1.3

284.96

397.51

u/l

0.50

223

Use of hypnotics and sedatives

443

1566

1.64

19.54

1.3

1.2

263.53

336.83

u/l

0.93

404

1472

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

396

1442

1.68

19.44

1.3

1.2

190.11

361.24

u/l

4.20

364

1350

Hypokalaemia

181

3.57

19.38

1.6

1.2

363.16

268.54

u/l

0.24

171

Other anxiety disorders

189

809

2.08

19.36

1.4

1.3

256.81

323.07

u/l

0.49

170

749

Disorders of lacrimal system

178

849

2.11

19.26

1.2

1.3

333.51

299.62

u/l

0.09

168

777

Syncope and collapse

170

703

2.15

19.01

1.2

347.28

381.44

u/l

0.13

155

648

General examination and investigation of persons without complaint and reported diagnosis

302

884

1.82

18.98

1.3

1.2

252.73

389.50

u/l

1.33

282

837

Neuralgia and neuritis, unspecified

5.53

18.86

1.1

1.2

443.44

454.70

u/l

0.02

Heart failure, not strict

305

1185

1.78

18.77

1.3

1.2

273.06

356.73

u/l

0.64

285

1095

Septicaemia

171

779

2.12

18.71

1.3

1.2

190.59

391.90

u/l

2.61

154

722

Alcohol withdrawal state with delirium

118

4.21

18.62

1.5

1.2

282.62

439.28

u/l

0.68

111

Diseases of the skin and subcutaneous tissue

427

1303

1.65

18.58

1.2

230.38

355.86

u/l

2.12

371

1238

Sequelae of external causes of morbidity and mortality

117

475

2.48

18.58

1.4

1.2

242.08

313.84

u/l

0.50

112

435

Other symptoms and signs involving the digestive system and abdomen

131

3.99

18.55

1.2

1.1

236.49

223.67

u/l

0.11

123

Type 2 diabetes, definitions combined

387

1388

1.67

18.39

1.3

1.2

200.72

364.57

u/l

3.64

357

1299

Obesity related asthma

148

670

2.22

18.32

1.3

1.2

224.29

420.38

u/l

1.64

139

618

Acute tubulo-interstitial nephritis

250

1203

1.85

18.28

1.2

203.00

337.13

u/l

2.19

237

1118

Haemorrhoids and perianal venous thrombosis

111

443

2.52

18.23

1.1

1.2

195.01

389.89

u/l

2.03

106

403

Hernia of abdominal wall

196

989

1.99

18.22

1.5

1.2

507.32

328.37

u/l

0.48

177

918

Other bacterial intestinal infections

297

2.88

18.17

1.1

1.2

195.17

344.50

u/l

1.67

279

Other heart diseases, wide

380

1419

1.67

18.11

1.3

1.2

248.20

343.43

u/l

1.34

344

1335

Other pulmonary diagnosis

324

922

1.76

18.05

1.3

1.2

353.72

373.11

u/l

0.08

290

865

Oedema, not elsewhere classified

121

503

2.40

18.01

1.7

1.2

188.02

433.09

u/l

1.98

112

463

COPD differential diagnosis

324

923

1.76

17.98

1.3

1.2

352.20

367.24

u/l

0.06

291

866

Type 2 diabetes, strict (exclude DM1)

387

1398

1.66

17.94

1.3

1.2

200.72

363.35

u/l

3.64

357

1309

Diseases of appendix

311

1653

1.72

17.88

1.3

1.2

235.07

339.05

u/l

1.74

292

1541

Abnormal findings on diagnostic imaging of other body structures

206

3.28

17.85

1.3

293.18

316.89

u/l

0.07

190

ILD differential diagnosis

323

923

1.76

17.75

1.3

1.2

353.23

367.24

u/l

0.05

290

866

Endocrine, nutritional and metabolic diseases

333

977

1.74

17.72

1.3

1.2

306.72

357.79

u/l

0.34

297

931

Dermatitis and eczema

434

1789

1.59

17.60

1.2

263.16

324.49

u/l

0.77

396

1682

Excluding asthma or asthma-COPD overlap

322

922

1.75

17.59

1.3

1.2

353.64

373.11

u/l

0.08

288

865

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

190

589

2.05

17.58

1.3

1.2

215.87

452.23

u/l

2.01

177

562

Hypermobility syndrome

4.72

17.53

1.4

1.2

208.70

337.90

u/l

0.48

Hypertensive diseases

320

1044

1.74

17.51

1.4

1.2

236.22

392.82

u/l

2.01

292

984

Hypertension

319

1041

1.74

17.42

1.4

1.2

235.89

393.10

u/l

2.01

291

983

Fall on same level

468

1668

1.57

17.28

1.3

1.2

323.16

313.18

u/l

0.07

446

1550

Antihypertensive medication - note that there are other indications

236

678

1.91

17.24

1.3

1.2

311.55

407.71

u/l

0.59

217

645

Obesity due to excess calories

197

1021

1.94

16.98

1.3

1.2

257.90

355.87

u/l

0.90

184

941

Bacterial infection, other or unspecified

204

960

1.92

16.93

1.2

202.99

359.29

u/l

2.42

188

893

Appendicitis, broad definition

306

1652

1.70

16.87

1.3

1.2

236.86

339.23

u/l

1.68

288

1540

Diaphragmatic hernia

146

682

2.15

16.75

1.2

402.15

322.14

u/l

0.17

131

634

Diabetes medication

415

1585

1.59

16.66

1.3

1.2

199.19

348.10

u/l

3.72

379

1486

Allergic asthma (mode), excluding more controls

103

407

2.49

16.62

1.4

1.3

243.05

308.22

u/l

0.72

384

Fracture of rib(s), sternum and thoracic spine

128

572

2.25

16.41

1.3

1.2

203.18

457.99

u/l

2.36

119

527

Type 2 diabetes, definitions combined, including avohilmo

382

1399

1.62

16.27

1.4

1.2

200.95

359.51

u/l

3.50

352

1310

Appendectomy

267

1482

1.74

16.24

1.3

232.47

329.59

u/l

1.48

253

1381

Bacterial Sepsis

178

800

1.99

16.21

1.2

239.74

387.70

u/l

1.32

161

742

Kela-code for severe mental illness

160

784

2.05

16.20

1.2

1.3

272.68

356.55

u/l

0.50

147

720

Asthma/COPD (KELA code 203)

376

1653

1.61

16.04

1.3

1.2

208.44

344.20

u/l

3.33

355

1544

Finngen Rheumatological endpoints

394

1404

1.60

15.98

1.3

1.2

215.74

354.30

u/l

2.68

371

1310

Allergic asthma (mode)

103

416

2.44

15.89

1.4

1.3

243.05

305.90

u/l

0.70

391

Other external causes of accidental injury

342

1027

1.67

15.85

1.3

1.2

298.88

315.30

u/l

0.10

318

956

Other noninfective gastroenteritis and colitis

110

468

2.36

15.80

1.2

1.3

350.93

292.17

u/l

0.23

104

430

Use of disulfiram, acamprosate or naltrexone

162

3.43

15.74

1.4

1.3

226.19

401.99

u/l

1.14

148

Acute appendicitis

286

1598

1.69

15.72

1.4

1.2

237.39

342.17

u/l

1.62

269

1490

Other systemic involvement of connective tissue (FG)

108

454

2.37

15.71

1.5

1.2

278.69

307.82

u/l

0.12

102

414

Problems related to lifestyle

172

3.34

15.69

1.5

1.2

312.32

356.66

u/l

0.18

164

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

248

1313

1.76

15.49

1.2

237.23

332.93

u/l

1.21

229

1218

Open wound of head

202

1076

1.85

15.29

1.2

271.64

348.70

u/l

0.67

191

989

Superficial injury of head

404

2.44

15.14

1.6

1.2

287.95

349.06

u/l

0.22

368

Impingement syndrome of shoulder

103

435

2.38

15.10

1.2

343.30

434.54

u/l

0.29

403

Heart failure and antihypertensive medication

100

263

2.52

15.09

1.4

1.1

197.10

603.32

u/l

1.73

250

Ventral hernia

102

429

2.39

15.09

1.4

1.3

317.60

360.65

u/l

0.14

397

Hypertensive Heart Disease

305

2.53

15.09

1.2

1.1

167.71

533.94

u/l

1.97

285

Dermatitis

240

1378

1.75

14.93

1.2

1.3

286.84

337.72

u/l

0.37

218

1290

Disorders of eyelid, lacrimal system and orbit

328

1591

1.62

14.83

1.2

272.40

317.57

u/l

0.23

308

1481

Other (not insulin) diabetes medications

380

1451

1.58

14.81

1.2

198.37

356.67

u/l

3.65

348

1359

Pruritus

174

3.25

14.74

1.1

1.2

205.18

274.29

u/l

0.54

163

Other joint disorders

345

1132

1.63

14.67

1.3

1.2

195.13

359.03

u/l

3.52

320

1055

Other neurological diseases

275

1313

1.69

14.63

1.2

1.3

242.18

328.11

u/l

1.14

255

1215

Other arrhythmias

255

1135

1.72

14.54

1.2

232.21

363.11

u/l

1.60

233

1061

Disorders of adult personality and behaviour

126

589

2.15

14.51

1.3

212.48

335.21

u/l

1.56

113

548

Other acute lower respiratory infections

211

1124

1.80

14.38

1.3

234.43

361.70

u/l

1.31

195

1034

Abnormalities of heart beat

126

587

2.13

14.28

1.3

205.94

366.32

u/l

1.64

114

552

Diseases of salivary glands

338

2.53

14.22

1.3

188.39

275.81

u/l

1.56

316

Acute appendicitis, no complications

227

1298

1.75

14.22

1.4

1.2

235.16

338.92

u/l

1.36

215

1212

Unspecified mental disorder

170

893

1.91

14.17

1.2

1.3

263.08

340.52

u/l

0.50

156

819

Early onset COPD, excluding more controls

339

2.52

14.11

1.5

1.3

186.07

492.60

u/l

1.92

322

Autoimmune diseases related-to ILD

332

1844

1.59

14.06

1.3

1.2

256.61

326.37

u/l

0.93

304

1729

Biguanides

373

1470

1.57

14.05

1.2

198.31

355.30

u/l

3.64

344

1373

Arthropathies

355

1135

1.59

13.84

1.3

1.2

204.91

358.75

u/l

3.13

332

1058

Iron deficiency anaemia

159

816

1.94

13.80

1.4

1.3

194.24

353.30

u/l

2.14

152

745

Radiculopathy

213

2.93

13.76

1.4

1.2

192.85

342.44

u/l

1.87

196

Cutaneous abscess, furuncle and carbuncle

110

498

2.22

13.76

1.3

165.52

377.69

u/l

3.47

100

458

Other and unspecified dermatitis

199

1110

1.80

13.73

1.2

1.3

258.43

339.74

u/l

0.63

178

1036

Nutritional anaemias

183

968

1.85

13.66

1.3

1.2

211.55

328.64

u/l

1.56

174

887

Any reimbursement code in KELA

228

638

1.79

13.61

1.4

1.2

256.46

418.97

u/l

1.35

210

601

Oxicams

101

238

2.42

13.52

1.3

354.94

251.37

u/l

0.41

222

Dental pulpitis 1, only avohilmo

422

1452

1.52

13.45

1.3

1.2

243.45

340.61

u/l

1.47

389

1356

Insulin medication

227

1124

1.73

13.43

1.3

1.2

168.95

371.30

u/l

4.34

204

1043

Acute renal failure

330

2.50

13.41

1.2

193.55

356.05

u/l

1.98

301

Dental pulpitis 4, only avohilmo

420

1448

1.52

13.27

1.3

1.2

243.84

341.21

u/l

1.46

386

1353

Sleep disorders (combined)

382

1638

1.53

13.21

1.3

1.2

312.39

310.98

u/l

0.01

353

1532

Hypertensive heart and/or renal disease

100

336

2.32

13.17

1.2

1.1

166.34

504.98

u/l

2.04

316

Injuries to the knee and lower leg

454

1755

1.48

13.15

1.3

1.2

259.89

326.83

u/l

0.87

430

1634

Specific personality disorders

104

470

2.22

13.09

1.3

217.88

356.12

u/l

1.43

435

Mental and behavioural disorders due to sedatives or hypnotics

108

3.74

13.08

1.2

188.43

419.22

u/l

0.93

Personality disorders

118

561

2.11

13.07

1.3

272.99

345.55

u/l

0.37

107

520

Accidents

328

1027

1.60

13.04

1.3

1.2

308.45

315.30

u/l

0.04

305

956

Benign neoplasm of colon, rectum, anus and anal canal

217

886

1.76

13.03

1.2

369.07

344.53

u/l

0.06

195

827

Volume depletion

123

3.52

12.91

1.1

1.2

176.38

317.35

u/l

1.14

115

Emotionally unstable personality disorder

227

2.80

12.86

1.4

1.3

162.98

328.19

u/l

2.00

210

Other and unspecified effects of external causes

115

546

2.12

12.79

1.4

1.3

315.33

296.98

u/l

0.09

105

499

Irregular menses

182

812

1.82

12.74

1.2

1.3

219.50

265.43

u/l

0.50

174

763

Fall on same level involving ice and snow

219

1287

1.71

12.64

1.4

1.2

253.58

331.08

u/l

0.60

206

1193

Gout

106

445

2.18

12.53

1.3

1.2

201.97

505.19

u/l

1.87

100

411

Benign neoplasm of colon, rectum, anus and anal canal

228

1221

1.69

12.50

1.2

358.96

321.74

u/l

0.10

204

1142

Infections of the skin and subcutaneous tissue

220

1293

1.70

12.48

1.2

1.3

188.00

350.75

u/l

3.90

204

1197

Other heart diseases

179

643

1.84

12.48

1.5

1.2

257.90

451.47

u/l

1.54

165

613

Somatoform disorder

289

2.54

12.39

1.3

177.60

276.07

u/l

1.62

267

Injury, poisoning and certain other consequences of external causes

206

576

1.80

12.39

1.3

1.2

297.96

323.15

u/l

0.11

194

531

Transport accidents

174

849

1.82

12.36

1.2

229.69

335.68

u/l

1.09

162

788

Hypothyroidism (congenital or acquired)

223

2.40

12.33

1.2

294.94

353.29

u/l

0.16

214

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

108

3.64

12.31

1.2

175.97

444.89

u/l

1.39

External causes of morbidity and mortality

258

773

1.68

12.22

1.3

1.2

324.71

324.61

u/l

0.00

243

717

Other arthrosis

202

828

1.75

12.07

1.2

444.72

385.82

u/l

0.15

193

769

Heart failure,strict

190

772

1.78

12.07

1.3

1.2

220.27

368.74

u/l

1.19

179

709

Insulin, intermediate and long-acting

206

1183

1.71

12.03

1.3

1.2

165.64

357.98

u/l

4.38

183

1097

Non-invasive ventilation

291

2.46

11.98

1.1

1.2

209.34

579.19

u/l

1.74

280

Pure hypercholesterolaemia

266

1100

1.63

11.98

1.2

208.65

370.50

u/l

2.63

242

1034

Genitourinary diseases

239

706

1.70

11.97

1.3

1.2

343.47

402.05

u/l

0.33

218

650

Haemorrhage from respiratory passages

116

524

2.06

11.94

1.2

169.42

421.43

u/l

3.34

109

496

Autoimmune diseases excluding thyroid diseases

402

1502

1.49

11.82

1.4

1.2

313.90

321.42

u/l

0.03

371

1412

Bipolar affective disorders

351

2.35

11.77

1.2

292.15

353.40

u/l

0.22

327

Insulin, combination of fast acting with intermediate-acting or long-acting

227

1262

1.66

11.77

1.3

1.2

168.95

347.80

u/l

4.20

204

1171

Candidiasis

216

2.75

11.72

1.2

215.84

308.85

u/l

0.63

201

Dentofacial anomalies [including malocclusion]

111

532

2.07

11.72

1.4

1.3

243.08

298.75

u/l

0.35

102

499

Polycystic ovarian syndrome, consortium definition

262

972

1.63

11.67

1.2

1.3

212.65

260.61

u/l

0.65

246

910

Carpal tunnel syndrome

226

1233

1.66

11.60

1.2

356.05

329.28

u/l

0.08

213

1147

Maltreatment syndromes

4.12

11.59

1.4

1.3

232.69

425.31

u/l

0.65

Hypothyroidism, levothyroxine purchases

223

2.35

11.59

1.2

296.67

353.29

u/l

0.16

214

Hypothyroidism and >3 levothyroxin purchases

223

2.35

11.59

1.2

296.67

353.29

u/l

0.16

214

Obesity, other/unspecified

132

685

1.93

11.53

1.5

1.2

272.04

338.87

u/l

0.38

125

630

Diseases of pulp and periapical tissues, including avohilmo

400

1401

1.49

11.52

1.3

1.2

258.82

343.26

u/l

1.04

368

1309

Disorders of vestibular function (Vertigo)

172

964

1.78

11.50

1.2

193.31

356.05

u/l

2.36

162

888

Other symptoms and signs involving cognitive functions and awareness

158

814

1.83

11.45

1.1

1.2

235.86

371.59

u/l

0.96

148

751

ILD medications: immunosuppressive drugs

226

1319

1.65

11.40

1.3

1.2

223.63

334.58

u/l

1.89

210

1225

Bacterial pneumoniae

157

762

1.83

11.34

1.3

1.2

233.34

369.28

u/l

1.31

149

707

Enlarged lymph nodes

226

2.67

11.29

1.1

1.2

390.93

292.93

u/l

0.34

208

Behavioural syndromes associated with physiological disturbances and physical factors

124

635

1.96

11.25

1.4

1.3

214.54

328.42

u/l

1.50

117

583

Dental pulpitis 1

399

1406

1.48

11.18

1.3

1.2

260.07

342.21

u/l

1.00

367

1314

Gout, FINNGEN

106

515

2.07

11.17

1.3

1.2

201.97

426.13

u/l

1.52

100

477

Other postsurgical states

106

3.53

11.14

1.3

1.2

281.86

380.37

u/l

0.31

Schizophrenia or delusion

127

659

1.93

11.12

1.3

257.21

342.23

u/l

0.57

119

604

Other systemic involvement of connective tissue

109

537

2.04

11.06

1.4

1.2

278.61

279.66

u/l

0.00

103

493

Benign neoplasm: Colon

182

801

1.75

10.99

1.2

394.86

327.49

u/l

0.15

165

745

Injuries to the shoulder and upper arm

306

1684

1.53

10.98

1.3

1.2

318.29

327.55

u/l

0.06

286

1566

Dental pulpitis 4

398

1407

1.47

10.97

1.3

1.2

260.30

342.08

u/l

1.00

366

1315

Disorders of lipoprotein metabolism and other lipidaemias

297

1206

1.55

10.91

1.2

228.60

359.98

u/l

2.02

267

1136

Other enthesopathies

113

567

2.00

10.90

1.3

1.2

481.42

396.71

u/l

0.13

104

528

Diseases of pulp and periapical tissues

137

734

1.87

10.89

1.3

247.79

333.77

u/l

0.68

126

690

Schizophrenia, schizotypal and delusional disorders

126

659

1.92

10.79

1.3

253.29

342.39

u/l

0.61

118

604

Injuries to the abdomen, lower back, lumbar spine and pelvis

148

810

1.82

10.75

1.4

1.2

352.23

390.67

u/l

0.15

141

740

Coronary atherosclerosis

247

991

1.61

10.70

1.2

223.96

351.99

u/l

1.45

224

921

Chronic periapical parodontitis

399

2.19

10.66

1.3

264.48

394.50

u/l

0.61

375

Inflammatory diseases of female pelvic organs

220

1011

1.64

10.64

1.2

250.96

250.39

u/l

0.00

201

954

Complications of medical and surgical care

266

1626

1.56

10.63

1.3

188.03

334.93

u/l

3.68

245

1515

Other disorders of teeth and supporting structures

406

2.18

10.62

1.2

191.36

384.28

u/l

1.61

382

Diplopia

217

2.64

10.55

1.3

1.2

155.13

328.20

u/l

2.13

200

Urticaria and erythema

137

742

1.85

10.54

1.2

1.3

219.69

319.30

u/l

1.00

120

683

Other disorders of ear

339

1517

1.49

10.52

1.3

1.2

350.59

318.24

u/l

0.13

322

1407

Inflammatory bowel disease

126

665

1.90

10.51

1.3

279.01

342.45

u/l

0.42

113

611

Autoimmune diseases excluding thyroid diseases, strict definition

385

1468

1.46

10.51

1.3

1.2

317.99

324.48

u/l

0.03

357

1378

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

136

3.11

10.43

1.4

1.3

291.95

382.12

u/l

0.31

125

Chronic gastritis

475

2.07

10.42

1.2

1.1

174.95

405.14

u/l

1.88

444

Trochanteric bursitis

207

2.67

10.41

1.7

1.2

614.18

270.32

u/l

0.33

190

Presence of cardiac and vascular implants and grafts

167

720

1.76

10.38

1.3

1.2

186.82

413.34

u/l

2.69

158

667

Symptoms and signs involving the skin and subcutaneous tissue

251

1599

1.57

10.38

1.4

1.2

215.64

336.36

u/l

2.37

233

1492

Disturbances of skin sensation

107

537

2.00

10.35

1.2

234.06

344.07

u/l

1.07

497

Ulcerative colitis, NAS

237

2.55

10.31

1.5

1.3

354.98

362.99

u/l

0.02

221

Bacterial pneumonia (organism specified)

166

870

1.74

10.29

1.3

1.2

236.17

375.65

u/l

1.54

157

803

Systemic connective tissue disorders

128

685

1.88

10.25

1.4

1.2

269.24

261.93

u/l

0.03

119

630

Chronic laryngitis and laryngotracheitis

232

2.56

10.24

1.2

155.36

277.06

u/l

1.94

211

Polyneuropathies and other disorders of the peripheral nervous system

374

2.20

10.21

1.2

282.19

418.07

u/l

0.58

346

Exposure to other specified factors

272

1666

1.53

10.20

1.5

1.2

324.23

307.61

u/l

0.08

255

1553

Visual disturbances

175

1030

1.70

10.17

1.3

1.2

175.17

349.75

u/l

3.23

162

950

Diseases of arteries, arterioles and capillaries (FINNGEN)

299

2.16

10.13

1.2

303.36

570.22

u/l

1.00

284

Diseases of the respiratory system

240

744

1.62

10.09

1.3

1.2

279.55

344.16

u/l

0.40

220

698

Other extrapyramidal and movement disorders in other diseases

402

2.15

10.07

1.2

210.41

279.30

u/l

0.74

369

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

349

1620

1.47

10.02

1.2

216.23

343.98

u/l

2.42

322

1516

Benign neoplasm: Colon

185

1087

1.67

9.98

1.2

390.21

331.38

u/l

0.13

168

1011

Disorders of synovium and tendon

180

963

1.69

9.94

1.3

1.2

405.62

319.87

u/l

0.22

162

894

Other and unspecified nonorganic psychotic disorders

379

2.17

9.89

1.4

1.3

306.27

374.38

u/l

0.24

350

All-cause Heart Failure

198

862

1.66

9.88

1.3

1.2

223.22

370.21

u/l

1.28

186

793

Cramp and spasm

3.94

9.87

1.3

1.2

244.39

412.73

u/l

0.43

Sleep apnoea, including avohilmo

356

1588

1.46

9.83

1.2

320.42

316.11

u/l

0.02

330

1487

Inflammatory disease of uterus

237

2.50

9.81

1.1

1.2

369.18

232.77

u/l

0.36

218

Other CVD (FINNGEN)

124

2.94

9.80

1.5

1.2

127.00

787.20

u/l

1.35

116

Heart failure, strict

200

875

1.65

9.76

1.3

1.2

225.28

367.51

u/l

1.24

188

806

Ischaemic heart disease, wide definition

277

1132

1.53

9.75

1.3

1.2

258.32

374.08

u/l

1.15

249

1054

Conductive and sensorineural hearing loss

284

1297

1.52

9.73

1.3

1.2

364.95

330.51

u/l

0.11

267

1200

Other specified/unspecified arthritis

102

515

1.99

9.73

1.2

334.25

471.53

u/l

0.46

475

Venous thromboembolism

193

1145

1.64

9.69

1.2

209.64

340.28

u/l

2.20

181

1055

Tongue abnormality

3.44

9.60

1.2

1.3

274.58

377.28

u/l

0.27

Other special examinations and investigations of persons without complaint or reported diagnosis

270

884

1.55

9.48

1.4

1.2

284.02

389.50

u/l

0.98

243

837

Sensorineural hearing loss

266

1219

1.53

9.46

1.3

1.2

379.96

336.17

u/l

0.13

250

1128

Diseases of tongue

3.40

9.45

1.2

274.58

234.99

u/l

0.12

Medical observation and evaluation for suspected diseases and conditions

267

884

1.55

9.44

1.4

1.2

223.72

389.50

u/l

2.33

237

837

Atrial fibrillation and flutter

114

384

1.94

9.41

1.3

1.2

229.11

589.98

u/l

2.00

105

368

Ischemic heart diseases

280

1158

1.52

9.38

1.3

1.2

258.92

370.47

u/l

1.12

252

1080

Acute bronchitis

150

848

1.74

9.37

1.3

1.2

241.94

381.99

u/l

0.96

139

773

Bacterial pneumonia, not elsewhere classified

145

731

1.76

9.33

1.3

243.63

378.34

u/l

1.20

138

677

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

159

721

1.72

9.31

1.2

330.44

371.67

u/l

0.18

148

667

Visual disturbances and blindness

183

1119

1.64

9.24

1.3

1.2

176.43

341.69

u/l

3.33

169

1029

Urticaria

112

595

1.89

9.23

1.2

1.3

241.04

303.85

u/l

0.47

551

Autoimmune diseases

415

1507

1.41

9.14

1.3

1.2

335.99

320.81

u/l

0.06

375

1416

Benign neoplasm of other and ill-defined parts of digestive system

314

2.24

9.13

1.4

1.2

186.33

282.25

u/l

1.04

286

Renal failure

150

795

1.73

9.12

1.2

203.95

388.08

u/l

1.73

132

739

Arthrosis

263

943

1.54

9.10

1.3

1.2

204.30

370.38

u/l

2.66

250

873

Unspecified fall

175

1054

1.65

9.08

1.3

1.2

212.82

360.44

u/l

1.80

168

962

Used for control exclusion in common control thyroid runs

396

1418

1.42

9.04

1.3

1.2

417.05

304.78

u/l

0.52

360

1331

Other diseases of liver

316

2.23

8.99

1.3

397.72

295.38

u/l

0.34

294

Atrial fibrillation and flutter with reimbursement

295

2.05

8.96

1.3

1.1

216.09

643.49

u/l

1.80

282

Other cataract

154

695

1.72

8.95

1.2

152.68

395.83

u/l

3.56

148

642

Benign neoplasm of other and ill-defined parts of digestive system

317

2.22

8.93

1.4

1.3

186.33

316.27

u/l

1.42

288

Injuries to the ankle and foot

247

1486

1.52

8.84

1.3

1.2

221.26

334.16

u/l

1.66

234

1385

Retention of urine

119

548

1.84

8.83

1.4

1.2

237.07

412.33

u/l

1.08

111

507

Epilepsy

110

588

1.87

8.83

1.1

1.2

343.48

378.88

u/l

0.13

538

Lesion of ulnar nerve

256

2.36

8.80

1.4

1.2

330.38

385.97

u/l

0.26

235

Diseases of the ear and mastoid process

431

1573

1.39

8.75

1.3

1.2

356.37

314.15

u/l

0.21

406

1469

Disorders of skin appendages

171

1043

1.64

8.73

1.3

259.23

368.02

u/l

1.20

159

962

Injuries to the wrist and hand

354

1811

1.42

8.70

1.4

1.2

366.30

303.01

u/l

0.26

338

1687

Gonarthrosis

236

874

1.55

8.65

1.3

1.2

186.94

374.53

u/l

2.89

224

815

All influenza

469

1.97

8.60

1.2

1.3

199.63

315.07

u/l

2.26

434

Other diseases of upper respiratory tract

407

1523

1.40

8.58

1.2

1.3

349.98

302.44

u/l

0.30

372

1428

Other medical care

149

860

1.70

8.58

1.2

278.82

304.66

u/l

0.14

140

800

Cerebrovascular diseases (FINNGEN)

111

423

1.88

8.57

1.5

1.2

216.33

544.13

u/l

2.01

103

406

Mycoses

519

1.92

8.53

1.3

1.2

266.48

346.11

u/l

0.53

481

Other anaemias

142

800

1.72

8.53

1.3

1.2

292.87

360.59

u/l

0.33

129

739

Adverse effects, not elsewhere classified

356

2.12

8.52

1.5

1.2

233.04

285.94

u/l

0.39

328

Other arthritis (FG)

113

619

1.83

8.50

1.3

327.54

459.57

u/l

0.51

103

569

Other and unspecified polyneuropathies, also in other diseases

324

2.17

8.48

1.3

1.2

306.91

414.20

u/l

0.35

300

Sleep disorders

404

2.04

8.44

1.4

1.3

220.57

317.41

u/l

0.98

373

Glucagon-like peptide-1 (GLP-1) analogues

189

976

1.60

8.38

1.2

205.49

369.54

u/l

1.97

174

902

Viral infections characterized by skin and mucous membrane lesions

149

887

1.68

8.37

1.4

1.3

434.22

327.49

u/l

0.31

139

812

Extrapyramidal and movement disorders

128

732

1.75

8.34

1.3

1.2

298.92

357.07

u/l

0.25

118

671

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

147

764

1.69

8.31

1.2

301.90

375.81

u/l

0.50

139

708

Other and unspecified anaemias

140

796

1.71

8.24

1.3

1.2

296.69

361.13

u/l

0.30

127

735

Neoplasms

288

1049

1.47

8.21

1.2

1.3

350.41

310.94

u/l

0.27

269

984

Aplastic and other anaemias

149

845

1.68

8.19

1.3

1.2

286.27

351.30

u/l

0.33

136

778

Pulmonary heart disease

103

555

1.86

8.17

1.2

214.05

377.42

u/l

1.60

509

Missing teeth due to accident, extraction or parodontitis

192

2.52

8.13

1.0

1.2

173.59

265.16

u/l

1.04

178

Dental caries, including avohilmo

275

947

1.49

8.12

1.3

1.2

322.44

337.05

u/l

0.07

252

889

Pulmonary embolism

103

558

1.85

8.04

1.2

214.05

420.84

u/l

1.82

512

Generalized anxiety disorder

248

2.31

8.03

1.5

1.2

266.80

275.93

u/l

0.05

231

Other diseases of anus and rectum

446

1.95

8.00

1.1

1.2

186.67

393.71

u/l

2.29

404

Dental caries 1, only avohilmo

281

976

1.47

7.98

1.2

316.93

334.62

u/l

0.09

259

914

Second line medication for Crohn's disease

203

1321

1.54

7.94

1.5

1.2

232.81

331.87

u/l

1.42

189

1226

Dental caries 1

274

948

1.48

7.91

1.3

1.2

323.24

336.81

u/l

0.07

251

890

Conjunctivitis (acute, non atopic)

103

562

1.83

7.80

1.4

1.2

207.27

354.68

u/l

2.05

512

Diseases of peritoneum

161

2.63

7.77

1.0

1.3

294.06

361.33

u/l

0.27

149

Diseases of oral cavity, salivary glands and jaws

336

1218

1.42

7.77

1.2

1.3

318.10

291.78

u/l

0.20

300

1157

Benign neoplasms

284

1105

1.46

7.75

1.2

1.3

488.38

311.41

u/l

0.77

262

1036

Erysipelas

184

1072

1.57

7.74

1.2

294.80

348.17

u/l

0.25

168

1000

DVT of lower extremities and pulmonary embolism

143

860

1.66

7.70

1.2

211.69

374.74

u/l

2.07

134

788

Early onset COPD

440

1.94

7.66

1.5

1.2

186.07

415.12

u/l

2.13

403

Ulcerative colitis

504

1.87

7.62

1.4

1.3

291.25

362.03

u/l

0.35

461

Inguinal hernia

205

899

1.54

7.58

1.2

353.27

365.90

u/l

0.03

188

838

Disorders of oesophagus in diseases classified elsewhere

7.43

7.57

1.6

1.1

199.05

368.07

u/l

0.34

Unspecified acute lower respiratory infection

275

2.19

7.50

1.3

1.2

182.98

475.91

u/l

2.60

258

Enteropathic arthropathies

5.24

7.47

1.5

1.3

268.66

661.96

u/l

0.48

Symptoms and signs involving the urinary system

265

1418

1.45

7.41

1.4

1.2

219.83

332.71

u/l

1.73

247

1312

COPD (mode)

102

444

1.83

7.41

1.4

1.2

198.31

428.32

u/l

1.79

417

Gonarthrosis [arthrosis of knee](FG)

273

1109

1.45

7.40

1.3

1.2

188.42

381.81

u/l

3.46

258

1033

COPD

149

753

1.64

7.35

1.4

1.2

183.16

413.92

u/l

3.20

138

700

Statin medication

254

969

1.47

7.34

1.3

1.2

246.67

340.36

u/l

1.03

235

905

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

130

775

1.68

7.31

1.3

212.04

334.82

u/l

2.13

122

711

Calculus of kidney and ureter

109

620

1.76

7.31

1.4

1.2

215.97

436.20

u/l

2.08

104

569

Angina pectoris

202

895

1.53

7.21

1.3

1.2

237.97

364.22

u/l

1.08

185

829

Umbilical hernia

514

1.84

7.19

1.7

1.2

722.81

422.34

u/l

0.39

475

Excessive, frequent and irregular menstruation

134

438

1.71

7.18

1.2

1.3

272.40

299.06

u/l

0.10

125

410

Blepharochalasis

544

1.81

7.14

1.1

1.2

221.04

289.37

u/l

0.43

494

Other hearing loss

479

1.85

7.08

1.2

291.80

332.19

u/l

0.13

441

Pulmonary heart disease, diseases of pulmonary circulation

108

619

1.75

7.06

1.2

209.41

402.29

u/l

1.89

100

566

Major coronary heart disease event excluding revascularizations

221

1027

1.49

7.03

1.3

1.2

249.50

355.72

u/l

0.86

212

940

Diseases of inner ear

183

1175

1.53

6.96

1.3

1.2

197.15

345.38

u/l

2.63

172

1088

Abnormal findings on diagnostic imaging of lung

152

935

1.59

6.83

1.1

1.2

185.28

369.62

u/l

3.03

140

867

Other and unspecified drugs and medicaments

143

2.61

6.78

1.3

308.94

315.58

u/l

0.02

129

Unstable angina pectoris

130

654

1.65

6.72

1.2

214.07

391.67

u/l

1.24

125

602

Vasomotor and allergic rhinitis

131

792

1.63

6.66

1.1

1.3

264.20

266.25

u/l

0.02

119

736

Sleep apnoea

317

1562

1.38

6.66

1.2

346.12

318.47

u/l

0.10

293

1461

COPD related to multimorbidity

129

660

1.65

6.65

1.4

1.2

187.37

373.03

u/l

2.14

118

611

Fissure and fistula of anal and rectal regions

371

1.95

6.63

1.1

1.2

239.46

487.11

u/l

1.68

338

Artrosis, including avohilmo

298

1169

1.40

6.62

1.3

292.56

338.60

u/l

0.25

278

1087

Dislocation, sprain and strain of joints and ligaments of knee

210

1329

1.47

6.62

1.4

1.2

237.26

332.23

u/l

1.19

198

1231

Paroxysmal tachycardia

329

1.93

6.58

1.3

1.2

269.87

524.33

u/l

1.04

312

Insulin, fast-acting

126

769

1.64

6.55

1.4

1.2

166.44

412.02

u/l

3.34

109

708

Dental caries 3

286

1039

1.41

6.49

1.2

332.94

329.36

u/l

0.02

263

978

Dissociative [conversion] disorders

3.67

6.48

1.4

1.2

171.65

251.98

u/l

0.41

Crohn disease

227

2.21

6.45

1.2

1.3

402.67

363.77

u/l

0.10

211

Direct fill therapy

227

2.21

6.45

1.3

208.36

362.68

u/l

1.48

210

Urolithiasis

113

674

1.68

6.45

1.4

1.2

213.10

419.85

u/l

2.12

108

617

Persons encountering health services in other circumstances, wide

429

1691

1.32

6.42

1.3

1.2

220.64

338.83

u/l

2.53

388

1593

Transient ischemic attack

173

943

1.52

6.39

1.2

247.17

363.99

u/l

1.10

160

868

Dental caries 3, only avohilmo

290

1061

1.40

6.35

1.3

1.2

336.21

328.47

u/l

0.04

267

998

Migraine, single triptan purchase ok & required. ICD-code if available is included

263

1264

1.41

6.35

1.3

1.2

273.02

311.24

u/l

0.33

248

1176

Triptan medication for migraine, single purchase ok

263

1264

1.41

6.35

1.3

1.2

273.02

311.24

u/l

0.33

248

1176

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

151

847

1.56

6.31

1.3

1.2

191.05

264.37

u/l

0.94

146

792

Other chronic obstructive pulmonary disease, including avohilmo

175

963

1.51

6.29

1.4

1.2

203.58

371.35

u/l

2.60

160

898

Correction of physiology of bite - very demanding therapy visit

3.88

6.28

1.3

1.2

258.67

456.70

u/l

0.38

Other chronic obstructive pulmonary disease

139

729

1.59

6.19

1.4

1.2

184.09

420.45

u/l

3.14

128

677

Injuries to the neck

447

1.82

6.09

1.2

1.3

182.61

335.86

u/l

2.99

412

Other and unspecified urticaria

355

1.92

6.07

1.1

1.3

273.07

305.02

u/l

0.12

327

Viral and other specified intestinal infections

354

1.91

6.02

1.2

1.3

285.63

300.37

u/l

0.05

329

Follicular cysts of skin and subcutaneous tissue

322

1.96

5.99

1.3

276.56

351.64

u/l

0.42

296

L04AX Other immunosuppressants

190

1300

1.46

5.97

1.3

232.30

330.82

u/l

1.35

176

1205

Diseases of the eye and adnexa

296

1077

1.38

5.93

1.3

1.2

265.01

379.45

u/l

1.32

273

1013

Persistent mood disorders

358

1.91

5.93

1.4

1.3

371.34

292.69

u/l

0.21

332

All influenza (not pneumonia)

262

2.07

5.92

1.2

258.21

385.45

u/l

1.18

244

Allergic rhinitis

105

623

1.67

5.92

1.1

1.3

273.84

325.21

u/l

0.42

578

Other and unspecified injuries of lower leg

112

2.70

5.92

1.5

1.2

186.97

296.05

u/l

1.09

101

Algoneurodystrophy

3.56

5.89

1.6

1.2

217.42

457.50

u/l

0.61

Viral haemorrhagic fevers, not elsewhere classified/unspecified

130

2.55

5.86

1.2

1.3

194.18

435.07

u/l

1.67

121

Benign neoplasms

346

1453

1.33

5.69

1.2

434.13

312.30

u/l

0.60

319

1371

COPD, hospital admission 2, with asthma infections

101

515

1.68

5.63

1.2

184.12

406.01

u/l

2.01

477

Oter anti-inflammatory and antirheumatic agents, non-steroids

214

1.90

5.61

1.2

1.3

187.82

246.31

u/l

1.10

202

Dental pulpitis 2, only avohilmo

236

854

1.42

5.59

1.3

1.2

326.86

346.42

u/l

0.09

214

801

Colectomy operation

289

1.98

5.57

1.2

287.54

311.25

u/l

0.14

263

Temporomandibular joint disorders, including avohilmo

137

892

1.54

5.48

1.4

1.3

306.64

264.34

u/l

0.21

129

829

Dental caries

495

1.73

5.46

1.2

1.3

247.47

375.14

u/l

0.97

463

Arthropod-borne viral fevers and viral haemorrhagic fevers

166

2.30

5.43

1.2

1.3

186.97

387.33

u/l

1.76

153

Chronic rhinitis, nasopharyngitis and pharyngitis

105

645

1.63

5.42

1.2

1.3

248.34

264.61

u/l

0.15

595

Injury of muscle and tendon at shoulder and upper arm level

123

786

1.57

5.40

1.2

1.3

331.13

387.13

u/l

0.21

114

724

Insulin, fast-acting or short human

126

810

1.56

5.37

1.4

1.2

166.44

400.37

u/l

3.31

109

748

Major coronary heart disease event

229

1093

1.40

5.37

1.2

211.40

347.07

u/l

1.75

217

1003

Malignant neoplasm of digestive organs

117

728

1.59

5.36

1.2

260.78

360.67

u/l

0.73

108

669

IBD patients in KELA-register

473

1.74

5.36

1.4

1.3

331.27

385.21

u/l

0.22

433

Noninflammatory disorders of female genital tract

138

444

1.57

5.33

1.3

285.24

297.22

u/l

0.04

128

415

Menorrhagia

115

392

1.63

5.28

1.1

1.3

173.85

309.93

u/l

1.08

108

366

Internal derangement of knee

124

796

1.56

5.28

1.5

1.3

205.80

401.25

u/l

2.59

117

739

Dentinal caries

429

1.77

5.26

1.1

1.3

265.52

398.62

u/l

0.85

401

Reimbursement for rheumatic diseases

194

1367

1.42

5.21

1.3

1.2

294.51

319.50

u/l

0.15

180

1269

Dental pulpitis 2

230

841

1.40

5.19

1.2

323.52

342.05

u/l

0.08

208

788

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

199

1408

1.41

5.18

1.2

1.3

164.89

336.24

u/l

5.01

187

1309

Pregnancy hypertension

135

800

1.52

5.16

1.3

202.35

232.52

u/l

0.37

130

747

STROKE

184

888

1.44

5.10

1.2

221.20

397.21

u/l

2.04

168

832

Nonalcoholic fatty liver disease

146

2.34

5.07

1.1

1.3

401.44

351.88

u/l

0.08

136

Other maternal disorders predominantly related to pregnancy

183

799

1.44

5.04

1.2

1.3

259.79

246.27

u/l

0.08

174

750

Other disorders of eyelid

136

874

1.51

4.98

1.2

203.89

312.88

u/l

1.02

126

802

Anorexia (incl.atypical)

2.64

4.98

1.7

1.3

218.00

346.90

u/l

0.56

5-aminosalicylic acid

425

1.75

4.95

1.5

1.2

331.83

369.80

u/l

0.13

386

Other abnormal uterine and vaginal bleeding

293

1.78

4.93

1.1

1.3

334.96

346.41

u/l

0.02

272

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

170

1160

1.44

4.93

1.2

1.3

211.30

316.44

u/l

1.84

153

1085

Benign neoplasm: Rectum

303

1.89

4.90

1.2

263.02

331.63

u/l

0.41

278

Any event in hilmo or specialist outpatient

+∞

4.85

1.3

0.0

1904.00

—

u/l

—

Acetic acid derivatives and related substances

257

1.73

4.83

1.3

1.2

495.24

243.20

u/l

0.97

240

Benign neoplasm: Rectum, anus and anal canal

348

1.82

4.81

1.3

1.2

252.54

318.90

u/l

0.45

319

Endometriosis of pelvic peritoneum

266

1.94

4.81

1.3

543.37

198.00

u/l

0.74

249

Disorders of other endocrine glands

137

906

1.49

4.80

1.4

1.2

242.61

297.38

u/l

0.63

122

836

Persons encountering health services for specific procedures, not carried out

132

2.36

4.73

1.2

2224.35

378.97

u/l

0.79

124

Inflammatory bowel disease, strict (require KELA)

492

1.67

4.70

1.4

1.3

331.27

368.63

u/l

0.15

451

Other and unspecified epidermal thickening

3.72

4.65

1.1

110.07

622.66

u/l

1.03

Disorders of ocular muscles, binocular movement, accommodation and refraction

148

1009

1.46

4.65

1.3

194.41

369.50

u/l

3.02

143

927

Disorders of vitreous body

152

1030

1.45

4.60

1.2

197.88

357.13

u/l

2.39

136

958

Contact with and exposure to communicable diseases

664

0.46

4.60

1.1

1.3

485.34

320.32

u/l

0.30

620

Hyperkinetic disorders, excluding more controls

118

2.40

4.58

1.1

1.2

310.83

291.52

u/l

0.07

110

Heart failure and bmi 25plus

109

480

1.57

4.58

1.2

223.62

341.49

u/l

0.64

104

439

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

322

1621

1.29

4.57

1.3

1.2

252.02

326.74

u/l

0.86

302

1514

Primary gonarthrosis, bilateral

163

999

1.43

4.56

1.4

1.2

187.81

365.33

u/l

2.95

153

929

Other specified and unspecified personality disorders

147

2.26

4.56

1.7

1.3

146.63

371.39

u/l

1.69

137

COPD, early/later onset

140

804

1.47

4.55

1.4

1.2

183.71

377.69

u/l

3.00

129

743

Open wound of wrist and hand

137

923

1.47

4.55

1.6

1.2

203.01

365.05

u/l

3.06

131

847

COPD, hospital admissions

139

800

1.47

4.53

1.4

1.2

181.83

379.59

u/l

3.07

128

739

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

135

2.31

4.52

1.1

1.3

327.90

295.81

u/l

0.08

124

Disorders of the thyroid gland

317

1603

1.29

4.49

1.3

1.2

374.75

304.48

u/l

0.33

294

1496

Persons encountering health services for examination and investigation

239

884

1.36

4.49

1.3

1.2

315.21

389.50

u/l

0.44

219

837

235

1.96

4.48

1.3

250.60

328.10

u/l

0.55

220

Benign neoplasm: Rectum

313

1.83

4.47

1.2

263.02

434.13

u/l

0.74

285

Chronic kidney disease

520

1.63

4.46

1.2

198.48

419.91

u/l

1.24

484

Primary coxarthrosis, bilateral

578

1.60

4.42

1.2

167.12

338.94

u/l

2.48

525

Benign neoplasm: Ascending colon

209

2.02

4.41

1.2

273.62

314.05

u/l

0.17

192

Polyp of the female genital tract

357

1.60

4.36

1.2

1.3

328.99

321.89

u/l

0.02

332

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

182

1316

1.38

4.34

1.2

1.3

158.68

339.11

u/l

5.05

172

1219

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

489

1.64

4.31

1.4

1.2

158.84

485.24

u/l

2.97

447

Gastrojejunal ulcer

9.02

4.29

1.0

1.1

250.38

370.67

u/l

—

Conduction disorders

436

1.62

4.28

1.2

224.66

424.36

u/l

1.27

403

Other and unspecified injuries of ankle and foot

3.06

4.24

1.7

1.1

201.64

472.25

u/l

0.68

Other viral diseases

599

1.57

4.22

1.3

407.78

334.21

u/l

0.22

547

Diseases of arteries, arterioles and capillaries

204

1121

1.36

4.19

1.2

276.41

351.58

u/l

0.58

183

1038

Disorders of vitreous body and globe

154

1062

1.42

4.19

1.2

200.30

359.64

u/l

2.49

138

989

Postmenopausal bleeding

280

1.65

4.19

1.1

1.2

292.37

339.00

u/l

0.11

264

Symptoms and signs involving the nervous and musculoskeletal systems

183

1333

1.37

4.19

1.1

1.3

258.28

334.06

u/l

0.72

169

1233

Preterm labour and delivery

501

1.62

4.17

1.1

1.2

362.40

216.66

u/l

0.58

468

Coagulation defects, purpura and other haemorrhagic conditions

343

1.75

4.14

1.4

1.2

194.91

328.02

u/l

1.72

316

Hypothyroidism, strict autoimmune

244

1222

1.32

4.13

1.2

288.97

307.62

u/l

0.12

223

1146

Benign neoplasm: Rectum, anus and anal canal

366

1.73

4.12

1.3

1.2

252.54

411.95

u/l

0.81

334

Disorders of sclera, cornea, iris and ciliary body

173

1257

1.38

4.05

1.2

1.3

197.81

343.18

u/l

2.83

163

1159

Benign neoplasm: Ascending colon

216

1.95

4.05

1.2

273.62

338.97

u/l

0.29

198

Disorders of lens

219

1032

1.34

4.01

1.2

223.66

399.04

u/l

2.36

200

962

Cardiomyopathy, other and unspecified

111

2.35

3.99

1.3

1.2

247.46

482.40

u/l

0.86

106

Persons with potential health hazards related to communicable diseases

821

0.55

3.99

1.1

1.3

411.03

318.41

u/l

0.23

761

Car occupant injured in other and unspecified transport accidents

363

1.71

3.96

1.1

1.3

233.52

323.45

u/l

0.61

339

Other and unspecified disorders of vitreous body

123

842

1.46

3.92

1.2

212.92

326.97

u/l

1.30

112

779

Hypothyroidism, other/unspecified

294

1518

1.28

3.90

1.3

1.2

273.78

305.67

u/l

0.26

270

1419

Hard cardiovascular diseases

250

1229

1.31

3.88

1.2

213.40

371.74

u/l

2.26

234

1135

Hypothyreosis and Thyroxine purchase for inclusion criteria

303

1572

1.27

3.87

1.3

1.2

271.92

322.89

u/l

0.46

279

1470

Hallux valgus (acquired)

103

492

1.52

3.85

1.3

1.2

205.43

286.10

u/l

1.20

455

Ganglion

344

1.72

3.83

1.2

369.06

400.04

u/l

0.09

317

Elevated blood glucose level

126

2.23

3.83

1.3

165.64

378.82

u/l

1.53

114

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

538

1.57

3.83

1.3

176.80

287.30

u/l

2.09

500

Persons encountering health services in other circumstances

118

810

1.46

3.81

1.3

263.38

388.06

u/l

0.81

104

751

Misadventures to patients during surgical and medical care

228

1.89

3.81

1.3

1.2

175.00

319.11

u/l

1.61

210

Non-rheumatic valve diseases

138

707

1.43

3.80

1.3

1.2

236.15

398.37

u/l

1.53

129

659

Mouth breathing

131

919

1.43

3.77

1.2

1.3

436.13

337.06

u/l

0.17

124

842

Female genital prolapse

327

1.57

3.75

1.1

1.3

301.22

334.07

u/l

0.09

306

Focal epilepsy, strict definition

355

1.69

3.71

1.1

1.2

345.31

333.32

u/l

0.04

326

Valvular heart disease excluding rheumatic fever

138

712

1.42

3.69

1.3

1.2

236.15

397.05

u/l

1.52

129

663

Focal epilepsy

386

1.66

3.68

1.1

1.2

338.07

336.67

u/l

0.00

353

Other inflammatory liver diseases

103

2.34

3.66

1.5

1.4

1468.83

364.61

u/l

0.44

Focal epilepsy, mode (most common among epilepsy diagnosis)

342

1.70

3.64

1.1

1.2

350.08

330.65

u/l

0.06

314

Subjective visual disturbances

489

1.58

3.62

1.4

1.2

148.46

310.99

u/l

4.19

450

Ankylosing hyperostosis [Forestier]

7.87

3.57

1.3

1.8

259.43

225.56

u/l

—

Glomerular diseases

315

1.72

3.53

1.2

141.44

378.57

u/l

3.73

291

Dental caries 3 and operation codes

301

1222

1.26

3.53

1.2

296.28

335.47

u/l

0.26

271

1155

Dental caries 1 and operation codes

286

1156

1.27

3.48

1.3

1.2

294.09

343.83

u/l

0.33

259

1092

Gingivitis and periodontal diseases

297

1214

1.26

3.47

1.2

1.3

299.00

292.13

u/l

0.05

266

1153

Dental caries 2 and operation codes, only avohilmo

140

1198

0.72

3.47

1.2

233.27

301.75

u/l

0.57

126

1101

Striking against or struck by other objects

100

680

1.47

3.44

1.6

1.3

202.32

406.83

u/l

2.69

622

Chronic diseases of tonsils and adenoids

256

1269

1.28

3.40

1.2

1.3

489.02

309.38

u/l

0.68

242

1190

Congenital malformations, deformations and chromosomal abnormalities

183

1324

1.33

3.38

1.2

1.3

251.16

341.30

u/l

1.12

170

1233

Undetermined asthma, excluding more controls

202

1.89

3.37

1.2

1.3

230.30

309.00

u/l

0.32

192

Disorders of breast

148

1005

1.37

3.34

1.2

172.92

260.24

u/l

1.69

139

941

Somnolence, stupor and coma

2.73

3.32

1.3

132.41

440.91

u/l

1.01

Haemorrhage in early pregnancy

534

1.52

3.32

1.3

285.00

229.38

u/l

0.48

497

Sequelae of injuries, of poisoning and of other consequences of external causes

477

1.56

3.29

1.2

1.3

315.13

364.20

u/l

0.19

435

Speech therapy

549

0.51

3.29

1.1

1.3

215.79

324.49

u/l

1.49

503

Benign neoplasm: Caecum

156

2.00

3.24

1.1

1.2

193.27

313.44

u/l

0.90

140

Undetermined asthma

205

1.86

3.23

1.2

1.3

230.30

309.95

u/l

0.33

195

Other contact dermatitis

129

2.10

3.23

1.4

1.3

180.78

317.95

u/l

0.87

119

Drug-induced cataract

3.19

3.22

1.2

1.1

179.83

610.70

u/l

0.81

Pneumonitis due to solids and liquids

116

2.16

3.22

1.2

1.3

211.14

427.77

u/l

1.13

107

Myocardial infarction

147

773

1.37

3.22

1.2

304.31

384.72

u/l

0.37

142

718

Nontoxic goitre/thyroid nodule

585

1.49

3.20

1.8

1.2

280.05

230.89

u/l

0.19

538

Familial hypercholesterolemia, with ischemic heart disease

130

2.08

3.17

1.3

1.1

168.27

386.02

u/l

1.42

120

Malignant neoplasm, wide definition for exclusion

294

1396

1.25

3.16

1.2

1.3

294.49

327.67

u/l

0.25

276

1302

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

294

1396

1.25

3.15

1.2

1.3

294.49

327.67

u/l

0.25

276

1302

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

311

1.68

3.15

1.5

1.3

230.78

337.03

u/l

1.09

288

Chronic sinusitis

129

938

1.38

3.10

1.1

1.3

191.27

313.19

u/l

1.62

120

873

Endometriosis ASRM stages 1,2

328

1.65

3.09

1.3

522.77

229.01

u/l

0.63

303

Benign neoplasm: Caecum

159

1.96

3.09

1.1

1.2

193.27

346.61

u/l

1.08

147

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

293

1396

1.24

3.06

1.2

1.3

295.01

327.67

u/l

0.25

275

1302

Myocardial infarction, strict

137

731

1.37

3.06

1.2

342.42

391.34

u/l

0.18

132

679

Persons encountering health services for specific procedures and health care

351

1789

1.22

3.04

1.2

1.3

481.47

282.08

u/l

0.84

318

1680

Other fall from one level to another

431

1.56

3.03

1.4

1.2

303.36

377.59

u/l

0.27

399

Non-ischemic cardiomyopathy

425

1.51

2.99

1.4

1.2

303.79

426.52

u/l

0.37

396

Acute appendicitis, with complications

370

1.60

2.99

1.2

1.3

246.29

437.92

u/l

1.49

338

COPD, hospital admissions 3, with asthma pneumonia sepsis

400

1.53

2.99

1.3

1.2

180.70

367.18

u/l

1.78

370

Nail disorders

120

2.09

2.98

1.1

1.2

114.04

420.04

u/l

2.24

107

Unspecified haematuria

123

764

1.38

2.98

1.5

1.2

239.08

406.58

u/l

1.61

114

710

Injuries to the hip and thigh

134

904

1.36

2.95

1.2

308.86

367.57

u/l

0.25

125

830

Endometriosis

101

417

1.44

2.95

1.3

374.39

306.36

u/l

0.19

390

Familial hypercholesterolemia

257

1.72

2.93

1.3

1.2

226.59

441.42

u/l

1.14

241

Primary_lymphoid and hematopoietic malignant neoplasms

444

1.54

2.90

1.3

1.2

200.43

435.67

u/l

1.48

408

L04AD Calcineurin inhibitors

177

1.87

2.90

1.2

1.3

185.35

381.44

u/l

1.53

165

Meniscus derangement

168

874

1.32

2.90

1.2

273.38

384.20

u/l

0.97

153

811

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

2.71

2.89

1.1

1.2

173.14

458.26

u/l

0.75

Golimumab

2.71

2.89

1.3

1.2

155.07

473.61

u/l

0.85

Other disorders of breast and lactation associated with childbirth

4.13

2.89

1.1

1.0

187.78

357.24

u/l

—

Coxarthrosis

145

732

1.35

2.88

1.2

247.57

394.49

u/l

1.16

136

680

Ulcerative colitis (strict definition, require KELA)

328

1.62

2.85

1.5

1.3

228.74

333.32

u/l

1.12

303

Correction of physiology of bite - demanding therapy visit

109

2.12

2.84

1.4

1.3

201.43

356.04

u/l

0.87

Fracture of lower leg, including ankle

165

1261

1.30

2.81

1.3

1.2

313.30

331.13

u/l

0.08

151

1165

Mild mental retardation

3.08

2.81

1.1

134.36

551.65

u/l

0.78

Triptan medication for migraine, min. 3 purchases

169

1024

1.30

2.79

1.4

1.3

279.75

273.05

u/l

0.04

161

961

Papulosquamous disorders

119

872

1.37

2.78

1.2

319.42

375.55

u/l

0.22

106

808

Exclusions for E4_PCOS_CONSORTIUM

225

1119

1.26

2.77

1.3

1.2

264.29

293.21

u/l

0.22

208

1051

Inflammatory disorders of breast

2.17

2.77

1.2

187.33

329.74

u/l

0.63

Puerperal sepsis

239

1.72

2.76

1.3

166.29

235.25

u/l

1.11

218

320

1.60

2.75

1.2

187.78

276.28

u/l

0.85

302

Female infertility

343

1.48

2.75

1.3

231.88

278.94

u/l

0.24

323

Primary_lymphoid and hematopoietic malignant neoplasms

450

1.51

2.75

1.3

1.2

200.43

399.34

u/l

1.43

413

Focal brain injury

2.32

2.74

1.2

1.3

240.17

443.01

u/l

0.91

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

363

1.57

2.74

1.4

1.3

233.65

399.88

u/l

1.43

333

Persons encountering health services for other counselling and medical advice, not elsewhere classified

355

1685

1.20

2.74

1.4

1.2

203.90

339.01

u/l

2.99

323

1587

Sulfasalazine

582

1.45

2.71

1.2

285.70

341.16

u/l

0.30

531

Osteoporosis with pathological fracture (FG)

2.15

2.70

1.1

1.3

148.67

435.80

u/l

1.30

Other follicular disorders

2.15

2.70

1.2

1.3

240.38

462.33

u/l

0.94

Complications of labour and delivery

181

780

1.30

2.70

1.2

275.67

247.05

u/l

0.17

167

733

Vulvovaginal ulceration/inflammation in other diseases

2.22

2.63

1.2

1.3

129.53

255.96

u/l

1.40

Malignant neoplasm of breast

860

0.70

2.62

1.1

1.2

172.44

265.10

u/l

1.36

800

Medical abortion

192

816

1.28

2.62

1.2

203.59

264.46

u/l

0.82

176

769

Psoriasis

595

1.43

2.62

1.2

278.37

399.85

u/l

0.62

549

Presence of other functional implants

159

865

1.30

2.60

1.2

208.84

354.00

u/l

1.97

147

801

Benign mammary dysplasia

267

1.65

2.58

1.2

161.51

262.98

u/l

1.00

243

Propionic acid derivatives

281

1.47

2.57

1.3

1.2

450.78

244.42

u/l

0.73

261

Other epidermal thickening

2.37

2.56

1.1

1.2

102.62

461.76

u/l

1.48

Bicipital tendinitis

2.36

2.56

1.2

208.56

440.79

u/l

0.75

Viral pneumonia

200

1.75

2.55

1.1

1.3

230.07

351.95

u/l

0.59

185

Pacemaker

581

1.42

2.55

1.3

1.2

233.65

375.38

u/l

0.98

533

Dialysis, with operation codes

215

1.73

2.55

1.2

1.3

137.81

401.61

u/l

3.04

197

Psoriasis vulgaris

362

1.55

2.55

1.2

332.65

368.94

u/l

0.11

332

Anankastic personality disorder

2.43

2.54

1.1

1.2

414.73

428.02

u/l

0.02

Conductive hearing loss, unspecified

136

1.92

2.50

1.3

161.62

336.94

u/l

1.25

125

Gonarthrosis,primary

279

1445

1.22

2.49

1.3

1.2

182.79

352.29

u/l

4.16

261

1347

Malignant neoplasm

290

1423

1.21

2.45

1.2

288.33

326.12

u/l

0.32

271

1327

Disorders of conjunctiva

247

1692

1.22

2.45

1.5

1.2

206.20

337.95

u/l

3.17

236

1577

Rheumatoid arthritis

585

1.40

2.45

1.3

1.2

277.11

428.86

u/l

0.87

542

Excessive vomiting in pregnancy

130

1.93

2.45

1.2

1.3

527.84

239.65

u/l

0.36

119

Other noninflammatory disorders of uterus, except cervix

268

1.53

2.44

1.3

1.2

163.42

361.68

u/l

1.08

250

Diseases of male genital organs

161

628

1.30

2.43

1.2

1.3

489.26

382.74

u/l

0.22

150

583

Coronary revascularization (ANGIO or CABG)

128

673

1.33

2.42

1.2

139.77

405.01

u/l

3.52

122

626

Complications of genitourinary prosthetic devices, implants and grafts

2.96

2.41

1.2

1.1

331.80

346.41

u/l

—

Other diseases of blood and blood-forming organs, wide

416

1.49

2.40

1.6

1.2

408.54

305.61

u/l

0.35

380

Pyoderma

3.36

2.40

1.0

1.1

101.22

802.73

u/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

273

1.62

2.39

1.6

1.3

201.34

343.80

u/l

1.47

254

Rubella [German measles]

2.27

2.35

1.0

1.2

1356.69

550.53

u/l

0.30

442

1.45

2.34

1.2

322.91

301.09

u/l

0.05

413

Colonic or urogenital fistula

551

1.42

2.32

1.1

1.3

239.75

353.22

u/l

1.20

505

Disorders of choroid and retina

238

1420

1.22

2.31

1.3

1.2

252.56

345.09

u/l

0.80

215

1322

Malignant neoplasm of breast, HER2-negative

837

0.72

2.31

1.1

1.2

174.92

268.09

u/l

1.32

779

Injuries to the elbow and forearm

206

1509

1.23

2.29

1.3

1.2

231.29

341.41

u/l

1.43

195

1397

Calcific aortic valvular stenosis, including rheumatic fever

524

1.42

2.29

1.2

176.13

397.95

u/l

2.00

484

Ingrowing nail

2.23

2.27

1.1

1.2

94.56

532.21

u/l

1.70

Nephropathy related operations

208

1.69

2.26

1.2

131.27

402.75

u/l

3.05

190

Acute suppurative otitis media

470

1.43

2.26

1.2

1.3

354.85

290.82

u/l

0.24

434

Dental operations

209

864

1.24

2.26

1.2

330.46

345.16

u/l

0.06

182

831

Atopic dermatitis

156

1046

1.27

2.25

1.2

1.3

179.59

312.27

u/l

3.25

142

981

Other diseases of hard tissues of teeth

191

1144

1.25

2.25

1.2

1.3

319.09

291.56

u/l

0.14

174

1089

Emphysema

2.05

2.21

1.1

1.2

154.47

444.89

u/l

1.45

Suppurative and unspecified otitis media

650

1.35

2.21

1.5

1.3

253.55

322.56

u/l

0.58

603

Other disorders of skin and subcutaneous tissue

200

1489

1.23

2.19

1.3

1.2

204.84

342.86

u/l

2.46

174

1394

Hordeolum and other deep inflammation of eyelid

2.13

2.18

1.1

1.3

239.99

469.18

u/l

0.72

Hypothyroidism, strict autoimmune, 3 medication purchases required

259

1468

1.20

2.18

1.1

1.2

288.67

325.64

u/l

0.27

238

1372

Calcific aortic valvular stenosis, diagnosis (helper)

522

1.41

2.17

1.2

177.29

398.32

u/l

1.97

482

Operations 2 for CAVS

522

1.41

2.17

1.2

177.29

398.32

u/l

1.97

482

Calcific aortic valvular stenosis, operated

524

1.40

2.13

1.2

177.29

397.75

u/l

1.97

484

Calcific aortic valvular stenosis

524

1.40

2.13

1.2

177.29

397.75

u/l

1.97

484

Wet age-related macular degeneration

254

1.59

2.11

1.1

1.2

462.71

286.17

u/l

0.31

241

Assault by unspecified means

2.72

2.11

1.2

443.70

793.44

u/l

—

Dislocation, sprain and strain of joint and ligaments of hip

2.46

2.10

1.3

1.1

192.58

497.86

u/l

0.70

Dental caries 2, only avohilmo

156

1541

0.80

2.10

1.1

1.3

391.70

313.62

u/l

0.19

141

1440

Other and unspecified mononeuropathies, also in other diseases

2.57

2.10

1.2

384.91

589.61

u/l

0.31

D07AA Corticosteroids, weak (group I)

283

1.56

2.09

1.3

180.89

288.24

u/l

1.20

262

Exclusions for E4_PCOS_BROAD

300

1.54

2.07

1.9

1.3

204.10

361.10

u/l

1.63

275

Other diseases of pleura

123

843

1.29

2.05

1.2

167.70

370.31

u/l

3.36

111

779

Senile cataract

180

899

1.24

2.05

1.2

232.96

408.16

u/l

1.91

163

839

Abnormalities of forces of labour

169

1.72

2.03

1.3

163.83

226.38

u/l

0.85

157

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

592

1.37

2.03

1.3

244.38

382.12

u/l

0.98

544

Other symptoms and signs involving the nervous and musculoskeletal systems

118

912

1.30

2.02

1.1

1.3

281.28

366.48

u/l

0.52

105

841

Conjunctivitis

219

1580

1.21

2.01

1.5

1.2

205.89

342.56

u/l

2.97

208

1469

Motorcycle rider injured in noncollision transport accidents

2.51

2.01

1.3

1.1

201.64

653.74

u/l

0.93

Other disorders of conjunctiva

239

1.59

2.01

1.2

183.26

309.00

u/l

1.21

218

Dental caries 2 and operation codes

157

1551

0.80

2.00

1.2

1.3

226.56

329.21

u/l

1.09

141

1451

Exposure to other and unspecified inanimate mechanical forces

104

1.93

2.00

1.2

1.3

268.45

444.26

u/l

0.72

Atopic dermatitis, strict definition with reimbursement

576

1.37

1.98

1.2

1.3

178.68

319.67

u/l

2.34

538

Other and unspecified follicular disorders

2.29

1.98

1.2

1.4

230.38

478.12

u/l

0.65

Atrophic disorders of skin

264

1.56

1.97

1.1

1.2

129.49

281.58

u/l

2.46

244

Herpesviral [herpes simplex] infections

186

1.67

1.97

1.2

1.3

222.88

304.62

u/l

0.62

172

Iridocyclitis

428

1.43

1.94

1.2

207.73

329.35

u/l

1.73

388

Dental caries 2

162

1571

0.81

1.94

1.2

1.3

384.56

312.13

u/l

0.18

146

1469

Major anomalies of jaw size

2.46

1.93

1.2

1.1

204.36

550.67

u/l

0.75

Anti-inflammatory and antirheumatic products, non-steroids

282

1.39

1.93

1.2

461.83

243.69

u/l

0.76

262

Residual foreign body in soft tissue

2.12

1.92

1.6

1.2

349.83

462.63

u/l

0.21

Type 1 diabetes

497

1.39

1.89

1.2

173.37

493.86

u/l

2.56

460

Other diseases of the respiratory system

340

1.47

1.88

1.2

184.28

303.45

u/l

1.14

310

Other respiratory disorders and diseases

340

1.47

1.88

1.2

184.28

303.45

u/l

1.14

310

Coronary artery bypass grafting

371

1.40

1.86

1.1

1.2

151.32

495.46

u/l

2.38

348

Coxarthrosis [arthrosis of hip](FG)

151

876

1.25

1.86

1.2

240.23

410.54

u/l

1.51

142

810

Diffuse large B-cell lymphoma, helper endpoint

2.21

1.84

1.2

1.3

134.62

398.75

u/l

0.87

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

2.21

1.84

1.2

1.3

134.62

398.75

u/l

0.87

Disturbances of smell and taste

2.21

1.84

1.2

1.3

189.00

493.96

u/l

1.00

Seropositive rheumatoid arthritis

474

1.39

1.84

1.4

1.2

279.93

324.98

u/l

0.21

433

Diabetic retinopathy, strict definition

388

0.61

1.82

1.1

1.4

72.73

223.31

u/l

10.70

357

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

2.13

1.82

1.0

1.3

244.21

429.38

u/l

0.56

Vestibular neuronitis

145

1.73

1.81

1.6

1.3

215.56

337.49

u/l

0.75

133

Etanercept

101

1.89

1.80

1.1

1.3

200.21

348.11

u/l

0.67

Atherosclerosis, excluding cerebral and coronary sclerosis

110

683

1.29

1.80

1.1

1.2

208.96

391.82

u/l

1.77

636

Postprocedural musculoskeletal disorders, not elsewhere classified

116

1.82

1.78

1.2

1.3

174.29

330.74

u/l

0.99

106

Supplementary factors related to causes of morbidity and mortality classified elsewhere

641

1.33

1.78

1.4

1.2

599.38

346.57

u/l

0.36

592

Contact with machinery

192

1.62

1.77

1.2

243.61

494.09

u/l

1.88

174

Cerebrovascular diseases

210

1257

1.20

1.76

1.4

1.2

191.87

341.74

u/l

3.14

196

1161

Hyperlipidaemia, other/unspecified

100

731

1.30

1.75

1.1

1.2

235.06

386.70

u/l

1.23

683

Other and/or unspecified nontoxic goitre

139

1.73

1.75

2.5

1.2

150.67

288.29

u/l

0.99

124

Cerebral atherosclerosis

3.86

1.71

1.0

571.00

141.00

u/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

2.07

1.70

1.0

1.3

244.21

428.95

u/l

0.57

Other specified/unspecified soft tissue disorders

2.07

1.70

1.0

1.2

469.50

448.67

u/l

0.03

Deviated nasal septum

724

1.30

1.70

1.3

516.58

367.58

u/l

0.20

671

Car occupant injured in noncollision transport accident

2.19

1.67

1.3

323.42

638.94

u/l

0.58

Other degenerative diseases of the nervous system

320

1.40

1.67

1.2

194.19

351.85

u/l

1.11

302

Otitis externa

425

1.39

1.67

1.3

787.23

344.17

u/l

0.37

388

Maternal care for other known or suspected fetal problems

302

1.38

1.66

1.2

226.18

226.55

u/l

0.00

283

Coronary angioplasty

576

1.29

1.66

1.2

155.07

439.76

u/l

3.16

542

Sequelae of injuries of head

1.93

1.64

1.4

1.3

171.56

400.71

u/l

1.02

Injury of nerves at wrist and hand level

2.25

1.63

1.2

133.00

329.36

u/l

1.51

Glucosamine medication

134

864

1.24

1.62

1.2

380.06

332.59

u/l

0.09

127

793

Factors influencing health status and contact with health services

100

389

1.29

1.58

1.4

1.2

471.54

406.43

u/l

0.17

371

Emergency coronary revascularization (for ACS)

148

870

1.22

1.57

1.2

156.33

395.84

u/l

4.11

140

805

Allergic contact dermatitis

239

1.51

1.56

1.1

1.3

163.47

274.30

u/l

1.49

224

Event of undetermined intent

1.85

1.56

1.4

1.3

317.06

468.57

u/l

0.40

Haemangioma, any site

137

1.68

1.55

1.3

161.83

327.55

u/l

1.31

123

Invasive ventilation

122

1.73

1.54

1.4

1.2

230.14

431.76

u/l

0.98

111

Mumps

2.29

1.53

1.0

1.3

184.90

569.72

u/l

—

Peripheral arterial reconstruction

273

1.47

1.53

1.1

1.2

138.63

293.59

u/l

2.30

251

Cellulitis

407

1.38

1.53

1.2

170.00

398.29

u/l

2.66

371

Hyperkinetic disorders

182

1.58

1.52

1.1

1.3

310.83

384.85

u/l

0.27

164

Episcleritis

1.87

1.50

1.2

1.3

417.81

390.69

u/l

0.05

Motorcycle rider injured in other and unspecified transport accidents

1.87

1.50

1.5

1.4

229.75

568.20

u/l

1.20

Rheumatoid arthritis, including avohilmo

102

810

1.26

1.50

1.2

290.36

315.72

u/l

0.13

743

Anosmia

2.83

1.48

1.3

1.1

172.50

214.10

u/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

102

1.77

1.44

1.7

1.2

216.56

408.70

u/l

0.71

Toxic effect of contact with venomous animals

2.04

1.43

1.7

1.2

116.67

430.00

u/l

1.04

Diffuse large B-cell lymphoma

1.98

1.43

1.2

134.62

366.90

u/l

0.84

Scabies

1.98

1.43

1.5

1.3

113.92

460.30

u/l

1.45

Mental retardation

2.04

1.43

1.1

1.3

134.08

425.73

u/l

0.95

Other encephalitis

2.32

1.43

1.2

1.1

416.22

496.21

u/l

—

Encephalitis

2.26

1.40

1.2

416.22

486.40

u/l

—

Disturbance of activity and attention

171

1.56

1.38

1.1

1.3

305.19

391.80

u/l

0.30

156

Fracture at wrist and hand level

730

1.26

1.38

1.3

1.2

588.45

393.79

u/l

0.27

663

Other puerperal infections

127

1.66

1.36

1.1

1.2

166.86

277.49

u/l

1.26

113

Visual field defects

135

1.63

1.35

1.1

1.2

205.05

393.66

u/l

0.86

122

Non-follicular lymphoma, hilmo, excluding all cancers

143

1.61

1.35

1.3

1.2

149.83

339.01

u/l

1.64

128

Dental operations, only avohilmo

216

949

1.17

1.34

1.2

344.90

336.81

u/l

0.03

190

900

Any event in cancer register

291

1517

1.14

1.33

1.2

1.3

263.14

322.35

u/l

0.73

271

1417

Use of interferon beta-1a

0.00

1.31

0.0

1.2

—

564.03

—

Other retinal disorders

166

1132

1.18

1.27

1.3

1.2

247.53

348.06

u/l

0.71

150

1048

Other infectious diseases

122

1.64

1.27

1.2

222.35

357.42

u/l

0.55

109

Postmenopausal osteoporosis with pathological fracture

1.79

1.27

1.2

128.27

334.91

u/l

0.99

Schizotypal disorder

2.06

1.27

1.1

1.3

183.22

649.53

u/l

—

Benign neoplasm of other and unspecified sites

2.05

1.27

1.1

126.56

525.90

u/l

—

Pneumonia derived septicemia

2.05

1.27

1.2

145.89

526.82

u/l

—

Mental retardation, wide definition

1.91

1.22

1.1

1.3

134.08

414.36

u/l

0.99

Polyarthritis, unspecified

1.97

1.22

1.7

1.3

757.09

485.04

u/l

0.19

Fall involving bed

2.17

1.21

1.1

53.00

502.23

u/l

—

conjunctival haemorrhage

116

1.64

1.21

1.3

188.53

412.92

u/l

1.18

106

Fibroblastic disorders

408

1.33

1.21

1.3

1.2

877.69

430.04

u/l

0.38

376

Varicose veins

179

1161

1.17

1.20

1.3

1.2

249.73

338.90

u/l

0.87

167

1081

Type 1 diabetes, wide definition, subgroup 1

356

1.35

1.20

1.2

136.24

280.82

u/l

3.87

334

Sequelae of cerebrovascular disease

629

1.24

1.20

1.2

197.11

396.50

u/l

1.99

579

Haemangioma, any site

148

1.56

1.20

1.3

161.83

312.46

u/l

1.26

134

Maternal care for known or suspected fetal abnormality and damage

256

0.62

1.19

1.2

230.39

238.53

u/l

0.05

237

Foreign body or object entering through skin

1.71

1.17

1.1

1.3

121.06

453.20

u/l

1.74

Diseases of external ear

712

1.24

1.16

1.2

572.99

354.55

u/l

0.26

655

Other and unspecified corneal deformities and disorders

2.01

1.16

1.4

1.1

73.00

525.59

u/l

—

Hyperplasia of prostate

459

1.23

1.16

1.2

1.3

651.32

369.34

u/l

0.41

426

Abnormal findings on examination of urine, without diagnosis

1.81

1.15

1.2

1.3

530.46

415.06

u/l

0.19

Follow-up examination after treatment for conditions other than malignant neoplasms

130

714

1.19

1.14

1.2

247.98

408.55

u/l

1.35

114

673

Convergent concomitant strabismus

1.69

1.13

1.4

1.3

202.19

387.27

u/l

0.82

Bitten or struck by other mammals

191

1.47

1.13

1.1

1.3

148.96

350.85

u/l

2.38

177

Lichen planus

216

1.44

1.13

1.1

1.3

487.33

281.52

u/l

0.28

199

Non-follicular lymphoma

151

1.53

1.11

1.3

1.2

149.83

378.60

u/l

1.90

139

Unspecified kidney failure

135

1.56

1.11

1.2

133.80

374.28

u/l

1.79

128

Lesion of plantar nerve

1.67

1.10

1.3

1.2

236.13

346.89

u/l

0.34

Fracture of femur

411

1.29

1.08

1.2

325.62

312.77

u/l

0.04

379

Embedded and impacted teeth

390

1.29

1.08

1.2

1.3

857.07

339.52

u/l

0.46

361

Pediculosis, acariasis and other infestations

1.69

1.07

1.4

1.3

101.00

398.43

u/l

1.74

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.80

1.04

1.1

1.3

504.83

413.65

u/l

0.08

Benign neoplasm of other and unspecified sites

1.96

1.03

1.1

1.2

126.56

517.27

u/l

—

Other menopausal disorders

300

1.27

1.03

1.2

1.3

400.57

308.65

u/l

0.21

283

Unspecified event, undetermined intent

2.07

1.03

1.6

1.1

448.29

645.46

u/l

—

Peripheral artery disease

109

735

1.19

1.03

1.1

1.2

195.18

408.85

u/l

2.24

683

Benign lipomatous neoplasm of other sites/unspecified

138

1.52

1.02

1.2

1.3

517.05

331.22

u/l

0.28

126

Benign neoplasm of thyroid gland

1.92

1.02

1.3

1.1

208.33

547.85

u/l

—

Benign neoplasm: Skin of other and unspecified parts of face

171

1.46

1.02

1.0

1.2

640.37

284.88

u/l

0.35

156

Atopic dermatitis, strict definition

587

1.24

1.01

1.2

1.3

181.06

287.66

u/l

2.37

542

Chondromalacia

1.88

1.00

1.0

1.3

221.22

486.26

u/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.88

1.00

2.1

1.2

858.33

421.32

u/l

—

Use of donepezil

298

0.68

1.00

1.0

1.2

201.29

293.58

u/l

0.87

276

Myocardial infarction, unclassifiable

336

1.30

1.00

1.2

350.73

299.16

u/l

0.11

309

Prolonged pregnancy

249

0.66

0.98

1.1

1.2

187.56

228.56

u/l

0.42

231

Osteonecrosis

1.67

0.97

1.4

213.29

476.87

u/l

1.10

Disorders of optic nerve and visual pathways

148

1.49

0.97

1.1

1.3

291.55

366.30

u/l

0.31

135

Contusion of other and unspecified parts of foot

1.69

0.95

1.2

141.15

482.73

u/l

1.30

Benign lipomatous neoplasm of other sites/unspecified

141

1.49

0.94

1.2

1.3

517.05

333.12

u/l

0.28

131

Problems related to social environment

1.90

0.94

1.0

1.1

117.29

625.03

u/l

—

Benign neoplasm: Skin of eyelid, including canthus

268

1.35

0.94

1.3

1.2

181.84

284.91

u/l

1.11

247

Benign neoplasm of thyroid gland

1.74

0.92

1.3

1.1

208.33

470.32

u/l

—

Retinal detachments and breaks

744

1.20

0.91

1.3

1.2

260.41

356.37

u/l

0.50

691

Agranulocytosis

184

1.42

0.91

1.1

1.2

435.24

297.84

u/l

0.18

170

Other obstructive and reflux uropathy

1.75

0.90

2.1

1.2

304.45

399.47

u/l

0.19

Portal vein thrombosis

2.08

0.89

1.8

1.1

126.50

700.08

u/l

—

Diabetic retinopathy

546

0.82

0.89

1.2

1.3

106.03

216.87

u/l

5.65

510

Clear cell adenocarcinoma of kidney

1.70

0.89

1.1

1.3

504.83

440.55

u/l

0.06

COPD, hospital admissions 1, only main diagnosis

596

1.20

0.88

1.2

172.55

378.20

u/l

2.20

553

Benign neoplasm: Skin of other and unspecified parts of face

177

1.41

0.88

1.0

1.2

640.37

329.14

u/l

0.30

164

Procreative management

578

0.80

0.88

1.8

1.3

216.17

323.06

u/l

1.12

541

Other respiratory diseases principally affecting the interstitium

289

1.32

0.87

1.1

1.2

208.26

311.00

u/l

0.95

264

Anogenital herpesviral [herpes simplex] infection

103

1.56

0.87

1.1

1.3

188.00

350.44

u/l

0.81

Chronic periodontitis

255

1.34

0.86

1.2

249.03

373.14

u/l

0.50

239

Redundant prepuce, phimosis and paraphimosis

394

1.26

0.86

1.3

245.05

431.76

u/l

1.71

360

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.82

0.86

1.5

1.2

262.38

499.71

u/l

—

Pneumococcal septicemia

1.82

0.86

1.3

1.2

148.37

568.87

u/l

—

Hyperfunction of pituitary gland

1.67

0.85

1.2

157.75

405.09

u/l

0.86

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

145

1.45

0.84

1.1

1.2

133.71

281.40

u/l

1.20

130

Degeneration of macula and posterior pole

111

786

1.17

0.83

1.3

1.2

297.02

327.29

u/l

0.11

726

Stroke, including SAH

163

1068

1.13

0.80

1.3

1.2

190.32

360.00

u/l

2.95

152

985

Arterial embolism and thrombosis of lower extremity artery

1.67

0.78

1.0

1.1

184.81

460.14

u/l

—

Lichen planus, including avohilmo

339

1.27

0.78

1.0

1.3

395.09

289.20

u/l

0.19

314

Anomalies of dental arch relationship, including avohilmo

336

1.26

0.78

1.2

1.3

192.46

344.66

u/l

2.33

313

Other keratitis

182

1.38

0.77

1.3

179.08

405.52

u/l

2.08

168

Insulin, fast-acting (human)

243

1.32

0.76

1.1

1.3

74.89

391.46

u/l

5.34

222

Artificial joint operation, meniscal resection

262

1588

1.10

0.76

1.3

1.2

206.98

348.91

u/l

3.33

244

1478

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.77

0.76

1.0

1.1

196.00

637.43

u/l

—

Contact with sharp object, undetermined intent

1.77

0.76

1.0

1.1

146.33

618.10

u/l

—

Myeloid leukaemia

1.77

0.76

1.8

1.1

231.67

568.69

u/l

—

Myeloid leukaemia

1.77

0.76

1.8

1.1

231.67

564.34

u/l

—

Seropositive rheumatoid arthritis, wide

548

1.21

0.76

1.4

1.2

279.93

290.23

u/l

0.04

502

Leiomyoma of uterus

128

629

1.15

0.76

1.3

267.72

287.20

u/l

0.09

120

589

Bulimia nervosa (incl. atypical)

1.70

0.76

1.2

181.90

414.98

u/l

—

Secondary right heart disease

1.70

0.76

1.1

1.2

134.60

413.26

u/l

—

Benign neoplasm: Skin of eyelid, including canthus

279

1.29

0.75

1.3

1.2

181.84

316.24

u/l

1.44

255

Other pulmonary heart/vessel disease

1.65

0.75

1.1

1.2

130.55

391.66

u/l

0.97

Other and unspecified injuries of wrist and hand

1.67

0.74

1.0

1.1

223.22

311.57

u/l

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

1.64

0.73

1.7

1.3

187.89

390.54

u/l

—

Sub-endpoint used in defining T1D endpoints

605

1.19

0.73

1.2

177.95

342.05

u/l

2.00

553

Cleft lip, lip and palate or palate

2.01

0.73

1.0

1.2

761.40

720.25

u/l

—

Chronic tubulo-interstitial nephritis

1.58

0.71

1.1

1.2

457.67

463.02

u/l

—

Tonsillectomy and adenotomy

149

923

1.12

0.70

1.2

1.3

292.07

319.24

u/l

0.19

141

859

Benign neoplasm of meninges

160

1.38

0.70

1.2

173.18

267.57

u/l

0.62

147

Excessive attrition of teeth

108

509

1.15

0.70

1.3

322.35

238.46

u/l

0.45

477

Respiratory tuberculosis, not confirmed

1.55

0.69

1.1

1.2

187.00

378.17

u/l

—

Diseases of middle ear and mastoid

147

1072

1.12

0.69

1.4

1.3

259.79

356.69

u/l

0.96

136

990

Certolizumab pegol

1.86

0.68

1.4

1.1

178.80

645.05

u/l

—

Injury of muscle and tendon at forearm level

1.86

0.68

1.2

1.1

248.60

683.05

u/l

—

Pustulosis palmaris et plantaris

1.53

0.68

1.9

1.2

198.56

416.92

u/l

—

Specific development disorders of speech and language

1.53

0.68

1.2

404.00

460.38

u/l

0.10

Maternal care related to the fetus and amniotic cavity and possible delivery problems

116

599

1.14

0.67

1.3

1.2

273.28

221.78

u/l

0.26

109

568

Impacted maxillary molar

0.54

0.67

1.2

1.3

106.20

410.04

u/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

1.79

0.66

1.8

1.2

63.20

671.61

u/l

—

Other and unspecified diseases of blood and blood-forming organs

1.60

0.65

1.0

1.1

353.43

553.24

u/l

—

Burn and corrosion confined to eye and adnexa

1.60

0.65

1.6

1.3

123.57

581.97

u/l

—

Progressive vascular leukoencephalopathy

1.59

0.65

1.0

1.1

78.71

421.10

u/l

—

Amblyopia ex anopsia

1.58

0.65

1.0

1.2

116.27

439.73

u/l

1.29

Ankylosing spondylitis, strict definition

1.57

0.65

1.6

1.1

264.36

519.74

u/l

0.63

Abnormal findings on diagnostic imaging of central nervous system

1.62

0.65

1.3

253.50

442.42

u/l

—

Other noninflammatory disorders of cervix uteri

1.62

0.65

1.3

1.2

218.10

151.95

u/l

—

Other disorders of cornea

154

1.37

0.65

1.4

1.3

102.24

356.11

u/l

2.49

140

Undefined dementia

153

0.66

0.64

1.2

75.82

279.56

u/l

1.83

140

1.61

0.64

1.3

1.1

119.30

410.48

u/l

—

Polyuria

413

1.21

0.64

1.1

1.2

177.95

377.03

u/l

1.85

375

L02BB Anti-androgens

129

0.62

0.63

1.1

207.38

297.75

u/l

—

120

Unspecified dementia

149

0.66

0.62

1.2

75.82

222.01

u/l

2.21

140

Other/unspecified seropositive rheumatoid arthritis

543

1.18

0.62

1.2

286.62

291.71

u/l

0.02

497

Unspecified lump in breast

291

0.76

0.62

1.2

210.23

277.94

u/l

0.36

266

Type of accident

599

1.17

0.62

1.4

1.2

661.36

339.60

u/l

0.38

553

Other specified disorders of kidney and ureter

1.60

0.61

1.0

1.2

191.75

503.25

u/l

—

Benign neoplasm: Colon, unspecified

459

1.19

0.61

1.1

1.2

185.96

365.12

u/l

1.18

422

Benign neoplasm: Larynx

1.57

0.60

1.4

1.3

145.25

485.61

u/l

—

Stroke, excluding SAH

150

1004

1.11

0.60

1.3

1.2

186.74

367.60

u/l

2.96

140

924

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

536

1.18

0.60

1.2

290.75

291.75

u/l

0.00

491

Failed attempted abortion

0.00

0.59

0.0

1.1

—

940.94

—

Hidradenitis suppurativa

1.54

0.59

1.3

256.63

497.64

u/l

—

Amiodarone users

157

1.34

0.59

1.4

1.2

181.71

418.24

u/l

1.91

147

Malignant melanoma

243

0.74

0.59

1.1

1.2

436.22

282.07

u/l

0.33

224

Benign neoplasm: Larynx

1.51

0.58

1.4

1.3

145.25

467.19

u/l

—

Loose body in joint

1.72

0.57

1.0

1.3

160.33

675.10

u/l

—

Gonarthrosis, primary, with knee surgery

142

1046

1.11

0.57

1.4

1.2

176.34

387.15

u/l

3.57

131

973

Ischaemic Stroke, excluding all haemorrhages

138

939

1.11

0.57

1.3

1.2

169.08

371.44

u/l

3.42

128

864

Benign neoplasm: Colon, unspecified

465

1.18

0.57

1.1

1.2

185.96

356.53

u/l

1.26

429

Pregnancy with abortive outcome

173

822

1.10

0.57

1.2

186.35

264.18

u/l

1.21

153

773

Contraceptive management

117

734

1.12

0.56

1.2

1.3

298.13

354.32

u/l

0.31

109

691

Glaucoma-related operations

0.58

0.56

1.0

1.2

185.40

361.20

u/l

—

Traumatic amputation of wrist and hand

1.54

0.55

1.0

1.2

143.40

414.37

u/l

—

Benign neoplasm of urinary organs

1.54

0.55

1.1

1.2

130.60

433.39

u/l

—

Other disorders of binocular movement

1.58

0.54

1.2

114.83

500.18

u/l

—

Malignant neoplasm of kidney, except renal pelvis

142

1.34

0.54

1.1

1.2

377.89

398.56

u/l

0.03

133

Organic, including symptomatic, mental disorders

113

729

1.12

0.54

1.1

1.2

191.78

366.64

u/l

2.04

103

667

Supervision of normal pregnancy

283

0.83

0.54

1.2

1.3

227.49

260.76

u/l

0.22

271

Other benign neoplasm of uterus: Other parts/unspecified

1.48

0.53

2.0

1.1

266.89

320.58

u/l

—

Benign neoplasm of meninges

169

1.30

0.53

1.2

173.18

271.29

u/l

0.69

154

Chronic periodontitis, including avohilmo

251

1727

1.08

0.52

1.1

1.3

339.62

317.35

u/l

0.14

229

1617

Vascular syndromes of brain in cerebrovascular disorders

1.52

0.52

1.1

1.2

141.20

397.85

u/l

—

Granulomatous disorders of skin and subcutaneous tissue

1.50

0.51

2.0

1.1

141.17

523.44

u/l

—

Type 1 diabetes, wide definition

424

1.18

0.51

1.2

1.3

139.91

405.63

u/l

4.03

389

Unspecified urinary incontinence

135

1.34

0.51

1.4

1.3

131.89

304.17

u/l

1.34

121

Chronic nephritic syndrome

1.39

0.50

1.1

1.2

100.78

452.47

u/l

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

1.47

0.50

1.0

1.3

264.33

599.00

u/l

—

Pedestrian injured in collision with pedal cycle

1.47

0.50

2.0

1.1

325.17

579.36

u/l

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.47

0.50

1.0

1.3

177.67

450.97

u/l

—

Parodontitis

251

1725

1.07

0.50

1.1

1.3

339.62

317.44

u/l

0.13

229

1615

Malignant neoplasm of endocrine gland

118

1.36

0.50

1.0

1.2

173.00

326.24

u/l

0.89

107

Benign lipomatous neoplasm

603

1.14

0.50

1.2

466.56

375.06

u/l

0.21

556

Other peripheral vascular diseases

136

1.33

0.49

1.1

1.2

740.61

305.87

u/l

0.49

125

Optic neuritis

1.45

0.48

1.1

392.64

378.29

u/l

0.03

Other acquired deformities of musculoskeletal system and connective tissue

1.45

0.48

1.3

1.2

221.73

420.61

u/l

0.72

Other obstetric trauma

1.45

0.48

1.2

338.36

266.61

u/l

0.21

Coxarthrosis, primary

147

1168

1.09

0.48

1.2

232.96

334.74

u/l

0.96

138

1083

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

289

1.21

0.47

1.1

1.3

182.23

334.38

u/l

2.08

266

Parodontitis or operation codes

251

1728

1.07

0.47

1.1

1.3

339.62

317.21

u/l

0.14

229

1618

Other intracranial haemorrhages

1.49

0.47

1.0

1.3

213.43

480.88

u/l

—

LeFortI or BSSRO operation

1.47

0.47

1.1

1.3

141.40

440.60

u/l

—

Benign neoplasm: Cerebral meninges

146

1.30

0.47

1.3

1.2

178.79

284.59

u/l

0.61

133

Benign neoplasm of urinary organs

1.47

0.47

1.1

1.2

130.60

414.79

u/l

—

Isolated proteinuria

1.46

0.47

1.3

1.2

586.86

558.44

u/l

—

Malignant neoplasm of thyroid gland

111

1.35

0.46

1.0

1.3

176.27

332.78

u/l

0.84

101

Parodontitis and operation codes

236

1715

1.07

0.46

1.1

1.3

348.70

318.23

u/l

0.18

214

1608

Brain meningioma, excluding all cancers (controls excluding all cancers)

0.62

0.45

1.2

105.60

369.68

u/l

—

Malignant melanoma of skin

187

0.75

0.45

1.1

1.2

513.50

316.55

u/l

0.33

173

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

138

1.31

0.45

1.1

1.2

199.28

309.96

u/l

0.65

123

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

0.59

0.45

2.2

1.2

749.20

371.31

u/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

412

1.17

0.45

1.1

1.3

361.36

295.92

u/l

0.13

383

Leiomyoma of uterus

164

859

1.09

0.45

1.3

1.2

243.75

262.97

u/l

0.11

154

804

Burns and corrosions confined to eye and internal organs

1.40

0.45

1.6

1.4

123.57

567.44

u/l

—

Benign neoplasm: Other and unspecified parts of mouth

1.40

0.45

1.3

1.1

206.43

503.47

u/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.37

0.44

1.0

1.2

154.43

468.53

u/l

—

Postpartum haemorrhage

401

1.15

0.42

1.1

1.2

188.42

233.70

u/l

0.68

378

Burn and corrosion of wrist and hand

1.41

0.42

1.1

1.3

284.75

486.82

u/l

—

Congenital malformations of great arteries

1.54

0.41

1.0

1.2

219.00

609.00

u/l

—

Pustular psoriasis

1.43

0.41

1.8

1.3

183.10

392.78

u/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.52

0.41

1.2

1.1

131.80

691.25

u/l

—

Disease of hard tissues of teeth, NOS

0.00

0.41

0.0

1.0

—

391.75

—

Delivery

506

0.90

0.41

1.2

189.51

245.91

u/l

0.77

474

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

1.36

0.41

1.3

174.50

417.00

u/l

—

Benign lipomatous neoplasm

614

1.12

0.41

1.2

466.56

307.58

u/l

0.44

561

Impetigo

1.31

0.39

1.1

1.2

163.88

433.14

u/l

—

Use of fingolimod

0.00

0.39

0.0

1.2

—

1050.79

—

Parodontitis or/and operation codes

183

1015

1.07

0.39

1.1

1.3

364.17

274.88

u/l

0.55

164

933

Multiple delivery

148

0.74

0.38

1.0

1.2

244.64

290.72

u/l

0.16

134

Other benign neoplasm of uterus: Other parts/unspecified

1.35

0.38

2.0

1.1

266.89

445.74

u/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

118

745

1.09

0.36

1.2

180.01

335.26

u/l

2.31

108

691

Cholesteatoma of middle ear

0.64

0.35

1.4

1.2

230.60

388.46

u/l

—

Follow-up examination after treatment for malignant neoplasms

179

0.78

0.35

1.4

1.2

173.29

265.37

u/l

0.82

163

Benign neoplasm: Cerebral meninges

153

1.24

0.35

1.3

1.2

178.79

284.10

u/l

0.63

139

Hypertensive Renal Disease

1.40

0.35

1.2

158.33

518.47

u/l

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

163

1.23

0.34

1.1

1.2

361.05

350.66

u/l

0.01

148

Benign neoplasm: other/unspecified salivary gland

1.34

0.33

1.2

1.1

154.83

495.47

u/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

555

1.11

0.32

1.3

154.04

236.97

u/l

2.09

520

Sixth [abducent] nerve palsy

1.28

0.32

1.8

1.3

251.17

543.52

u/l

—

Acute posthaemorrhagic anaemia

1.28

0.32

1.3

1.1

194.50

526.40

u/l

—

Other benign neoplasms of uterus

1.35

0.32

1.9

1.1

266.30

360.75

u/l

—

Asthma mixed form (mode), excluding more controls

1.35

0.32

1.1

1.3

120.10

357.91

u/l

—

Erosion of teeth, including avohilmo

385

1.13

0.31

1.5

1.3

336.93

269.85

u/l

0.33

363

Cardiac arrest

1.32

0.30

1.1

1.2

251.55

1237.97

u/l

1.07

In situ neoplasms

724

0.91

0.29

1.2

201.95

294.07

u/l

0.94

664

Hyperprolactinaemia

1.25

0.29

1.3

1.2

181.86

421.69

u/l

—

Covid-19 confirmed case

574

1.10

0.28

2.0

1.2

237.29

346.54

u/l

0.88

529

Ulcer of lower limb, not elsewhere classified

223

1.17

0.28

1.1

1.2

250.55

354.43

u/l

0.39

206

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.29

0.28

1.3

1.2

174.50

411.15

u/l

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

1.25

0.27

1.6

1.3

1037.12

450.27

u/l

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1.23

0.27

1.3

1.2

1259.38

446.22

u/l

—

Benign neoplasm of major salivary glands

159

1.20

0.26

1.3

1.2

182.47

350.14

u/l

1.14

145

Persons encountering health services in circumstances related to reproduction

136

977

0.94

0.26

1.2

1.3

281.29

329.11

u/l

0.34

124

913

Benign neoplasm of other and unspecified female genital organs

0.69

0.26

1.0

1.2

97.00

377.08

u/l

—

Brain meningioma

0.68

0.26

1.2

105.60

394.20

u/l

—

Maternal care for known or suspected disproportion

1.23

0.25

1.1

1.2

167.89

254.79

u/l

—

Left ventricular outflow tract obstruction, narrow definition

1.23

0.25

1.1

1.4

166.44

405.48

u/l

—

Other or ill-defined heart diseases

1.23

0.25

1.0

1.3

329.67

538.88

u/l

—

Foreign body in respiratory tract

1.28

0.24

1.3

116.10

394.90

u/l

—

Family history of certain disabilities and chronic diseases leading to disablement

0.73

0.24

1.0

1.2

70.50

398.47

u/l

—

Benign neoplasm of major salivary glands

161

1.18

0.24

1.3

1.2

182.47

368.46

u/l

1.30

151

Degenerative diseases of the nervous system

436

0.91

0.23

1.2

180.42

298.38

u/l

1.68

404

Amputation of foot

1.32

0.23

1.0

1.3

77.00

506.73

u/l

—

Diabetic neuropathy

245

1.14

0.23

1.3

1.2

136.15

228.53

u/l

2.44

222

Other disorders of veins

836

0.93

0.23

1.2

273.70

332.24

u/l

0.26

776

All dysplastic lesions of the vagina

1.28

0.23

1.4

1.1

83.60

510.82

u/l

—

Systemic sclerosis (FG)

1.25

0.22

1.0

1.1

132.00

576.82

u/l

—

Sequelae of injuries of neck and trunk

1.25

0.22

1.4

1.3

95.60

621.69

u/l

—

Asthma mixed form (mode)

1.27

0.22

1.1

1.3

120.10

257.18

u/l

—

Hypermetropia

116

1.21

0.22

1.2

1.3

197.64

336.98

u/l

0.64

106

Delivery, wide proxy

401

0.93

0.21

1.1

1.2

337.42

228.65

u/l

0.31

376

Glaucoma suspect

729

1.07

0.21

1.0

1.2

158.46

350.77

u/l

2.60

676

Testicular dysfunction, other/unspecified

0.00

0.21

0.0

1.4

—

320.70

—

Acute drug-induced interstitial lung disorder

0.00

0.21

0.0

1.0

—

305.30

—

In situ neoplasms

677

0.93

0.21

1.2

201.95

313.55

u/l

1.02

624

Autoimmune hyperthyroidism

104

0.77

0.21

1.3

1.2

218.00

343.88

u/l

—

Systemic sclerosis

1.16

0.21

1.0

1.1

132.00

510.59

u/l

—

Congenital malformations of heart and great arteries

213

1.14

0.21

1.0

1.3

188.95

391.86

u/l

2.17

195

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

126

1.19

0.21

1.0

1.2

176.27

323.81

u/l

0.87

112

Scissor bite

1.16

0.21

1.4

1.2

189.60

490.70

u/l

—

Graves disease, strict definition

177

0.85

0.21

1.2

228.93

303.37

u/l

0.46

164

Stenosis and insufficiency of lacrimal passages

145

1.17

0.20

1.3

1.2

110.06

335.00

u/l

1.86

132

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.20

0.0

1.1

—

283.71

—

Diabetic retinopathy, excluding more controls

329

1.08

0.20

1.2

1.3

107.04

221.99

u/l

5.21

308

Hereditary corneal dystrophies

1.25

0.20

1.3

1.1

135.50

525.23

u/l

—

Disorder of external ear, unspecified

1.25

0.20

1.3

180.17

567.51

u/l

—

Dissection of aorta

1.23

0.20

1.2

1.1

108.67

392.20

u/l

—

Renal cell carcinoma of kidney

1.23

0.20

1.0

1.2

177.67

407.43

u/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.20

0.19

1.0

1.2

133.83

664.31

u/l

—

Systemic lupus erythematosus, unspecified

1.18

0.19

1.0

1.2

436.00

459.59

u/l

—

Entropion and trichiasis of eyelid

118

1.19

0.19

1.4

1.2

117.64

392.88

u/l

1.87

109

Other mental disorders due to brain damage and dysfunction and to physical disease

184

1.14

0.19

1.0

1.2

185.69

339.29

u/l

1.19

171

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

130

847

1.05

0.19

1.2

223.11

343.25

u/l

1.27

118

787

Systemic lupus erythematosus

1.13

0.18

1.0

1.2

436.00

429.23

u/l

—

Other hammer toe(s) (acquired)

280

1.11

0.18

1.4

1.2

224.85

307.59

u/l

0.58

256

Chronic suppurative otitis media, including avohilmo

128

1.17

0.18

3.7

1.3

165.80

332.86

u/l

0.95

115

Bilateral sagittal split ramus osteotomy operation

1.21

0.18

1.1

1.2

148.00

456.94

u/l

—

Disorders of speech understanding and production

1.21

0.18

1.3

1.2

354.57

527.16

u/l

—

Sequelae of infectious and parasitic diseases

121

0.83

0.18

1.1

1.3

800.80

348.61

u/l

—

109

Other disorders of optic [2nd] nerve and visual pathways

1.21

0.17

1.2

190.45

374.02

u/l

0.72

Hypertrophic cardiomyopathy

1.15

0.17

1.3

248.00

455.17

u/l

—

Malignant neoplasm of mesothelium and soft tissue

0.75

0.17

2.0

1.2

343.60

417.35

u/l

—

Disorders of orbit

0.73

0.17

2.0

1.4

146.60

454.56

u/l

—

Benign neoplasm of other and unspecified female genital organs

0.72

0.17

1.0

1.2

97.00

387.66

u/l

—

Male infertility

0.72

0.17

1.2

1.4

560.40

433.30

u/l

—

Other abnormal findings of blood chemistry

1.18

0.16

1.4

1.3

152.00

454.08

u/l

—

Basal cell carcinoma, including avohilmo

129

974

1.04

0.16

1.2

182.90

337.22

u/l

2.51

117

902

Other benign neoplasms of skin

744

1.05

0.16

1.2

393.53

354.03

u/l

0.09

688

Postpartum hemorraghe, all women as controls

494

1.07

0.15

1.1

1.3

188.42

255.98

u/l

1.07

465

Caught, crushed, jammed or pinched in or between objects

0.77

0.15

2.3

1.4

224.67

515.63

u/l

—

Chronic iridocyclitis

0.77

0.15

1.0

1.2

384.17

411.39

u/l

—

Basal cell carcinoma

125

958

1.04

0.14

1.2

183.98

340.62

u/l

2.48

114

885

Paralytic strabismus

112

1.16

0.14

1.4

1.2

163.15

376.18

u/l

1.29

103

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

108

715

1.04

0.14

1.2

178.23

340.38

u/l

2.29

662

Postpartum hemorraghe, parous women as controls

437

1.06

0.13

1.1

1.3

188.42

264.87

u/l

1.19

411

Dementia

543

0.95

0.13

1.2

178.21

313.36

u/l

1.44

499

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

110

728

1.04

0.13

1.2

178.33

337.15

u/l

2.28

675

Polypectomy (DHB20)

113

1.15

0.13

1.1

1.3

169.15

429.14

u/l

1.59

106

Squamous cell neoplasms and carcinomas of the skin

180

1.11

0.13

1.3

1.2

255.35

318.45

u/l

0.24

167

Fracture of forearm

130

1180

1.03

0.11

1.2

226.41

362.07

u/l

1.31

124

1089

Benign neoplasm of eye and adnexa

153

1.11

0.11

1.5

1.2

204.85

298.53

u/l

0.56

140

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

182

1.10

0.11

1.3

1.2

255.35

344.67

u/l

0.35

167

Abrasion of teeth

450

1.05

0.10

1.1

1.3

450.92

234.39

u/l

0.58

421

Malignant neoplasm of skin

134

1037

0.97

0.10

1.2

220.85

331.84

u/l

1.28

123

959

Other disorders of penis

154

1.10

0.10

1.1

1.3

129.65

406.65

u/l

3.00

142

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

1.14

0.10

1.4

1.1

164.00

528.36

u/l

—

Benign neoplasm: Conjunctiva

1.06

0.09

1.0

1.2

176.60

519.80

u/l

—

Benign neoplasm: Conjunctiva

1.04

0.09

1.0

1.3

176.60

543.10

u/l

—

Provisional assignment of new diseases of uncertain etiology

101

980

1.03

0.09

1.6

1.2

228.65

352.98

u/l

1.29

906

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

1.11

0.09

1.0

1.3

210.00

203.84

u/l

—

SLE, ICD10

1.09

0.09

1.0

1.2

436.00

443.26

u/l

—

SLE, strict definition

1.09

0.09

1.0

1.2

436.00

443.26

u/l

—

Codes for special purposes

101

981

1.03

0.08

1.6

1.2

228.65

352.65

u/l

1.29

907

Benign neoplasm: Skin of ear and external auricular canal

1.07

0.08

1.2

1234.00

482.61

u/l

—

SLE (Finngen)

1.05

0.08

1.0

1.2

436.00

448.94

u/l

—

Complications of the puerperium, not elsewhere classified

0.83

0.08

1.0

1.2

320.40

245.74

u/l

—

Papillary adenocarcinoma of thyroid gland

1.14

0.08

1.0

1.3

189.20

367.48

u/l

—

Glaucoma

125

1071

1.02

0.08

1.0

1.2

222.41

318.39

u/l

0.72

108

997

Single spontaneous delivery

504

0.97

0.07

1.2

198.25

246.25

u/l

0.62

472

Other malignant neoplasms of skin (=non-melanoma skin cancer)

121

933

1.02

0.07

1.2

181.92

341.45

u/l

2.47

110

861

Thyrotoxicosis with toxic multinodular goitre

1.05

0.07

1.0

1.2

164.33

358.03

u/l

—

Oral leukoplakia and related diseases

1.03

0.07

1.0

1.2

293.89

396.75

u/l

—

Laparoscopic right hemicolectomy

1.02

0.07

1.3

1.2

161.00

311.22

u/l

—

L01XE Protein kinase inhibitors

0.86

0.06

1.6

1.2

1030.75

410.46

u/l

—

Primary open-angle glaucoma, strict

477

0.96

0.06

1.1

1.2

332.10

333.29

u/l

0.00

444

Benign neoplasm: Choroid

0.85

0.06

2.0

1.2

240.17

364.73

u/l

—

Dementia, including avohilmo

581

0.97

0.06

1.2

180.33

318.94

u/l

1.60

533

Other complications of labour and delivery, not elsewhere classified

180

1.07

0.06

1.1

1.3

218.10

237.44

u/l

0.11

166

Melanocytic naevi

609

0.97

0.06

1.1

1.2

225.17

302.33

u/l

0.87

560

Respiratory insufficiency

101

0.89

0.06

1.6

1.2

85.08

358.11

u/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

122

1223

0.98

0.06

1.7

1.2

200.23

308.16

u/l

1.87

116

1139

Coxarthrosis, primary, with hip surgery

103

955

1.02

0.06

1.2

264.97

350.28

u/l

0.50

880

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

111

0.90

0.06

1.0

1.2

189.20

346.06

u/l

—

771

0.98

0.06

1.2

145.10

338.18

u/l

2.56

709

Primary open-angle glaucoma

592

0.97

0.05

1.1

1.2

297.16

307.50

u/l

0.03

548

Allergic conjunctivitis

135

1309

1.01

0.04

1.6

1.2

197.57

302.58

u/l

2.02

129

1220

Other benign neoplasms of skin

784

1.02

0.04

1.2

393.53

351.00

u/l

0.10

721

Other sexually transmitted chlamydial diseases

109

0.92

0.04

1.1

1.3

362.30

408.14

u/l

—

Injury of muscle and tendon at hip and thigh level

161

1.06

0.03

1.2

237.65

441.47

u/l

0.86

150

Actinic keratosis

686

0.98

0.03

1.1

1.2

148.40

347.25

u/l

2.26

631

Exposure to unspecified factor

256

1972

1.01

0.03

1.2

491.63

290.04

u/l

0.79

233

1850

Pregnancy, childbirth and the puerperium

334

1.02

0.02

1.2

308.91

223.71

u/l

0.22

313

Benign neoplasm of eye and adnexa

162

1.05

0.02

1.5

1.2

204.85

355.41

u/l

0.95

150

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

103

1.07

0.02

1.5

1.3

812.55

348.11

u/l

0.51

Spontaneous abortion

100

673

1.01

0.02

1.3

1.2

218.37

261.24

u/l

0.35

635

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

134

1102

0.99

0.02

1.3

1.2

385.17

314.48

u/l

0.14

127

1028

Benign neoplasm: salivary glands, exclude unknown (D119)

147

0.95

0.01

1.4

1.3

185.86

335.26

u/l

0.84

138

Melanocytic naevi

583

1.01

0.01

1.1

1.2

225.17

361.46

u/l

1.16

536

Skin changes due to chronic exposure to nonionizing radiation

716

0.99

0.01

1.1

1.2

147.55

339.25

u/l

2.29

659

Dental caries 3 and operation codes, only avohilmo

400

0.99

0.00

1.3

1.2

384.36

307.38

u/l

0.21

357

Care involving use of rehabilitation procedures

160

1523

1.00

0.00

1.1

1.3

220.74

284.23

u/l

1.38

145

1425

Seborrhoeic keratosis

433

0.99

0.00

1.2

149.96

313.18

u/l

2.79

402

Dental caries 1 and operation codes, only avohilmo

341

1.00

0.00

1.4

1.1

403.93

329.03

u/l

0.17

299

Combinations of oral blood glucose lowering drugs

596

1.01

0.00

1.2

197.49

445.22

u/l

2.43

551

Other benign neoplasms of uterus

1.05

0.00

1.9

1.1

266.30

400.51

u/l

—

Congenital malformations of eye, ear, face and neck

103

0.97

0.00

1.4

1.3

163.50

397.91

u/l

—

Benign neoplasm: Parotid gland

126

1.03

0.00

1.3

195.23

337.21

u/l

0.69

116

Benign neoplasm: Parotid gland

126

1.03

0.00

1.3

1.2

195.23

350.81

u/l

0.76

119

Cardiodefibrillation

784

1.01

0.00

1.2

252.15

396.06

u/l

1.22

726

Intracerebral haemorrhage

187

1.02

0.00

1.6

1.2

288.53

345.73

u/l

0.19

175

Memory loss

151

0.99

0.00

1.3

1.2

171.73

363.75

u/l

1.28

138

Malignant neoplasm of bladder

1.01

0.00

1.2

203.90

396.40

u/l

—

Chronic suppurative otitis media

113

0.97

0.00

4.5

1.3

178.18

348.20

u/l

0.75

101

Surgical ablation of atrial fibrillation

0.00

0.0

1.0

—

164.17

—

Cerebral oedema

0.00

0.0

1.3

—

120.67

—

Vertical strabismus

0.93

0.00

1.0

1.2

90.80

466.33

u/l

—

Giant cell arteritis

0.85

0.00

1.8

1.2

79.00

415.72

u/l

—

Examination and encounter for administrative purposes

0.97

0.00

1.0

1.3

95.33

324.82

u/l

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.0

1.4

—

137.00

—

Other congenital malformations of skin

0.94

0.00

1.2

1.3

102.33

398.47

u/l

—

Carcinoma in situ of prostate

0.00

0.0

1.0

—

210.00

—

Marasmic kwashiorkor

0.00

0.0

1.4

—

187.60

—

Benign neoplasm: Testis

0.00

0.0

1.2

—

334.22

—

Periodontosis

0.00

0.0

1.0

—

228.80

—

Disorders of phosphorus metabolism and phosphatases

0.00

0.0

1.0

—

385.11

—

Other specified and unspecified disorders of choroid

0.00

0.0

1.3

—

135.00

—

Other ill-defined and unspecified causes of mortality

0.89

0.00

1.0

1.2

143.36

435.43

u/l

—

Gangrene, not elsewhere classified

0.00

0.0

1.0

—

405.43

—

Benign neoplasm: Epididymis

0.00

0.0

1.4

—

138.20

—

Feeding problems of newborn

0.00

0.0

1.7

—

132.83

—

Malignant neoplasm of gum

0.00

0.0

1.3

—

155.38

—

Degenerative conditions of globe

0.00

0.0

1.0

—

102.40

—

Benign neoplasm: Scrotum

0.00

0.0

1.3

—

129.63

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.0

1.4

—

451.40

—

Chalazion

190

1.00

0.00

1.1

1.3

1357.53

344.09

u/l

0.39

174

Other disorders following mastoidectomy

0.00

0.0

1.4

—

125.20

—

Other acantholytic disorders

0.00

0.0

1.0

—

120.60

—

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

391.00

—

Bicuspidal aortic valve syndrome

1.00

0.00

1.0

1.4

197.80

473.38

u/l

—

Benign neoplasm: Skin of ear and external auricular canal

0.98

0.00

1.2

1234.00

445.96

u/l

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.0

—

117.00

—

Malignant neoplasm of penis

0.00

0.0

1.0

—

164.20

—

Pityriasis lichenoides et varioliformis acuta

0.00

0.0

1.0

—

2019.20

—

Polyglandular dysfunction

0.00

0.0

1.0

—

141.20

—

Felty syndrome

0.00

0.0

1.3

—

110.13

—

Other secondary gout

0.00

0.0

1.0

—

137.86

—

Fatigue fracture of vertebra

0.00

0.0

1.0

—

185.20

—

Intermittent hydrarthrosis

0.00

0.0

1.0

—

1916.40

—

Other fibroblastic disorders

0.00

0.0

1.3

—

183.14

—

Adult-onset Still disease

0.00

0.0

1.2

—

299.89

—

Hypersensitivity angiitis

0.00

0.0

1.0

—

108.00

—

Other specified/unspecified diseases of inner ear

0.00

0.0

1.3

—

118.50

—

Lipomatosis, not elsewhere classified

0.00

0.0

1.3

—

198.00

—

Other other unspecified disorders of the circulatory system

0.85

0.00

1.2

217.60

471.53

u/l

—

Nondiabetic hypoglycaemic coma

0.00

0.0

1.4

—

132.20

—

Maternal care for cervical incompetence

0.85

0.00

1.0

1.1

263.00

421.89

u/l

—

Crushing injury of forearm

0.00

0.0

1.4

—

93.40

—

Failed induction of labour

0.89

0.00

1.1

1.2

238.86

283.99

u/l

—

Sequelae of other and unspecified infectious and parasitic diseases

0.90

0.00

1.1

1.3

972.38

392.24

u/l

—

Carcinoma in situ of skin of lip

0.00

0.0

1.0

—

250.80

—

Sequelae of poliomyelitis

0.00

0.0

1.0

—

124.00

—

Benign neoplasm: Testis

0.00

0.0

1.3

—

444.86

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

1.4

—

138.00

—

Benign neoplasm: Choroid

0.94

0.00

2.0

1.3

240.18

401.50

u/l

—

Listeriosis

0.00

0.0

1.0

—

136.60

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

391.00

—

Malignant neoplasm of lip

0.00

0.0

1.0

—

140.50

—

Other surgical follow-up care

0.89

0.00

1.0

1.2

136.08

480.18

u/l

—

0.00

0.0

1.4

—

2301.40

—

Metabolic disorder, other/unspecified

0.00

0.0

1.3

—

405.56

—

Fitting and adjustment of external prosthetic device

0.00

0.0

1.4

—

124.00

—

Failure of sterile precautions during surgical operation

0.00

0.0

1.0

—

118.00

—

Defect, injury or illness of face

0.00

0.0

1.0

—

421.40

—

Discharge from other and unspecified firearms

0.00

0.0

1.5

—

171.00

—

Accident to watercraft causing drowning and submersion

0.00

0.0

1.0

—

449.00

—

Explosion of other materials

0.00

0.0

1.3

—

392.50

—

Other effects of reduced temperature

0.00

0.0

1.4

—

114.40

—

Non-seminoma of testis

0.00

0.0

1.3

—

330.67

—

Peripheral retinal degeneration

1.00

0.00

1.4

1.1

344.40

510.40

u/l

—

Traumatic cerebral oedema

0.00

0.0

1.0

—

577.60

—

Traumatic amputation of ankle and foot

0.00

0.0

1.3

—

353.83

—

Congenital retinoschisis

0.00

0.0

1.4

—

410.80

—

Congenital malformations of aortic and mitral valves

0.92

0.00

1.0

1.4

176.50

436.10

u/l

—

Mononeuritis multiplex

0.00

0.0

1.0

—

1694.50

—

Unspecified transport accident

0.00

0.0

1.3

—

113.50

—

L01XX Other antineoplastic agents

1.00

0.00

1.5

1.2

304.87

440.19

u/l

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.0

1.8

—

134.60

—

Toxic erythema

0.00

-0.00

0.0

1.4

—

1976.60

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amylase [Enzymatic activity/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS